Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number 001-40069

AmpliTech Group, Inc.

(Exact name of registrant as specified in its charter)

Nevada

27-4566352

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)

155 Plant Avenue

Hauppauge, NY 11788

(Address of principal executive offices) (Zip Code)

(631)-521-7831

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on
which registered

Common Stock, par value $0.001 per share

AMPG

The Nasdaq Stock Market LLC

Warrants to Purchase Common Stock

AMPGW

The Nasdaq Stock Market LLC

Indicate by check mark whether registrant (1) has filed all reports to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 23, 2024, the registrant had 9,717,113 shares of common stock, par value $0.001 per share, issued and outstanding.

AMPLITECH GROUP, INC.

QUARTERLY REPORT ON FORM 10-Q

March 31, 2024

TABLE OF CONTENTS

		PAGE
PART I - FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited)	4

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	32

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	35

Item 4.	Controls and Procedures	35

PART II - OTHER INFORMATION

Item 1.	Legal Proceedings	37

Item 1A.	Risk Factors	37

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	37

Item 3.	Defaults Upon Senior Securities	37

Item 4.	Mine Safety Disclosures	37

Item 5.	Other Information	37

Item 6.	Exhibits	37

SIGNATURES		38

Use of Certain Defined Terms

Except as otherwise indicated by the context, references in this report to “we,” “us,” “our,” “our Company”, “the Company”, “AmpliTech”, “Specialty” or “SMW” “Spectrum” or “SSM”, “AmpliTech Group MMIC Design Center” or “AGMDC”, “AmpliTech Group True G Speed Services” or “AGTGSS” are the combined business of AmpliTech Group, Inc., and its consolidated subsidiary, AmpliTech, Inc., and AMPG’s divisions Specialty Microwave, Spectrum Semiconductor Materials, AmpliTech Group MMIC Design Center and AmpliTech Group True G Speed Services.

CAUTIONARY STATEMENT ON FORWARD-LOOKING INFORMATION

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements discuss matters that are not historical facts. Because they discuss future events or conditions, forward-looking statements may include words such as “anticipate,” “believe,” “estimate,” “intend,” “could,” “should,” “would,” “may,” “seek,” “plan,” “might,” “will,” “expect,” “anticipate,” “predict,” “project,” “forecast,” “potential,” “continue” negatives thereof or similar expressions. Forward-looking statements speak only as of the date they are made, are based on various underlying assumptions and current expectations about the future and are not guarantees. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, level of activity, performance or achievement to be materially different from the results of operations or plans expressed or implied by such forward-looking statements.

We cannot predict all the risks and uncertainties. Accordingly, such information should not be regarded as representations that the results or conditions described in such statements or that our objectives and plans will be achieved, and we do not assume any responsibility for the accuracy or completeness of any of these forward-looking statements. These forward-looking statements are found at various places throughout this Quarterly Report on Form 10-Q and include information concerning possible or assumed future results of our operations, including statements about potential acquisition or merger targets; business strategies; future cash flows; financing plans; plans and objectives of management; any other statements regarding future acquisitions, future cash needs, future operations, business plans and future financial results, and any other statements that are not historical facts.

These forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to risks, uncertainties and other factors. Many of those factors are outside of our control and could cause actual results to differ materially from the results expressed or implied by those forward-looking statements. Considering these risks, uncertainties and assumptions, the events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of the Quarterly Report on Form 10-Q. All subsequent written and oral forward-looking statements concerning other matters addressed in this Quarterly Report on Form 10-Q and attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this Quarterly Report on Form 10-Q.

Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise.

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

AmpliTech Group, Inc.

Condensed Consolidated Balance Sheets

	March 31,			December 31,
	2024			2023
	(Unaudited)
Assets
Current Assets
Cash and cash equivalents	$	2,376,894		$	6,726,013
Accounts receivable		1,309,400			2,542,710
Inventories, net		7,245,607			6,537,578
Prepaid expenses		1,922,561			1,342,335
Total Current Assets		12,854,462			17,148,636

Property and equipment, net		2,509,365			2,599,448
Operating lease right of use assets		3,403,891			3,538,798
Intangible assets, net		2,946,668			2,984,133
Goodwill		4,696,883			4,696,883
Cost method investment		348,250			348,250
Security deposits		109,480			91,481

Total Assets	$	26,868,999		$	31,407,629

Liabilities and Stockholders’ Equity
Current Liabilities
Accounts payable and accrued expenses	$	965,273		$	846,179
Customer deposits		25,616			14,239
Current portion of financing lease obligations		17,003			16,799
Current portion of operating lease obligations		495,595			541,324
Current portion of notes payable		63,196			80,841
Total Current Liabilities		1,566,683			1,499,382

Long-term Liabilities
Financing lease obligations, net of current portion		28,209			32,537
Operating lease obligations, net of current portion		3,086,880			3,171,979
Deferred tax liability		24,000			24,000
Total Liabilities		4,705,772			4,727,898

Commitments and Contingencies		-			-

Stockholders’ Equity
Common stock, par value $0.001, 500,000,000 shares authorized, 9,717,113 and 9,714,613 shares issued and outstanding, respectively		9,717			9,715
Additional paid-in capital		36,578,394			36,439,739
Accumulated deficit		(14,424,884	)		(9,769,723	)

Total Stockholders’ Equity		22,163,227			26,679,731

Total Liabilities and Stockholders’ Equity	$	26,868,999		$	31,407,629

See accompanying notes to the condensed consolidated financial statements

AmpliTech Group, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

	2024			2023
	For The Three Months Ended
	March 31,			March 31,
	2024			2023

Revenues	$	2,293,331		$	4,112,299

Cost of Goods Sold		1,410,701			2,295,768

Gross Profit		882,630			1,816,531

Operating Expenses
Selling, general and administrative		2,033,747			2,086,912
Research and development		276,755			348,730
Total Operating Expenses		2,310,502			2,435,642

Loss From Operations		(1,427,872	)		(619,111	)

Other Income (Expenses)
Loss on investment in digital assets		(3,248,911	)		-
Unrealized gain on investments		-			18,546
Realized gain on investments		25,965			4,828
Interest income (expense), net		(4,343	)		13,771
Total Other Income (Expenses)		(3,227,289	)		37,145

Net Loss Before Income Taxes		(4,655,161	)		(581,966	)

Provision For Income Taxes		-			-

Net Loss	$	(4,655,161	)	$	(581,966	)

Net Loss Per Share;
Basic and diluted	$	(0.48	)	$	(0.06	)

Weighted Average Common Shares Outstanding;
Basic and diluted		9,715,712			9,635,709

See accompanying notes to the condensed consolidated financial statements

AmpliTech Group, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

	Shares		Value		Capital			Deficit			Equity
	For The Three Months Ended March 31, 2024

	Common Stock				Additional						Total
	Number of		Par		Paid-In			Accumulated			Stockholders’
	Shares		Value		Capital			Deficit			Equity

Balance, December 31, 2023		9,714,613	$	9,715	$	36,439,739		$	(9,769,723	)	$	26,679,731

Stock based compensation		-		-		138,657			-			138,657

Common stock issued for vesting of RSU’s		2,500		2		(2	)		-			-

Net loss for the three months ended March 31, 2024		-		-		-			(4,655,161	)		(4,655,161	)

Balance, March 31, 2024		9,717,113	$	9,717	$	36,578,394		$	(14,424,884	)	$	22,163,227

	For The Three Months Ended March 31, 2023

Balance, December 31, 2022		9,634,613	$	9,635	$	36,050,161		$	(7,304,284	)	$	28,755,512
Balance		9,634,613	$	9,635	$	36,050,161		$	(7,304,284	)	$	28,755,512

Stock based compensation		-		-		66,041						66,041

Common stock issued for vesting of RSU’s		2,500		2		(2	)		-			-

Net loss for the three months ended March 31, 2023		-		-		-			(581,966	)		(581,966	)

Balance, March 31, 2023		9,637,113		9,637		36,116,200			(7,886,250	)		28,239,587
Balance		9,637,113		9,637		36,116,200			(7,886,250	)		28,239,587

See accompanying notes to the condensed consolidated financial statements

AmpliTech Group, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	March 31,			March 31,
	For The Three Months Ended
	March 31,			March 31,
	2024			2023
Cash Flows from Operating Activities:
Net loss	$	(4,655,161	)	$	(581,966	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		129,123			114,445
Operating lease costs		134,907			150,045
Stock based compensation		138,657			66,041
Inventory reserve		3,000			-
Loss on investment of digital assets		3,248,911			-
Change in fair value of marketable securities		-			(18,546	)
Changes in Operating Assets and Liabilities:
Accounts receivable		1,233,310			(55,750	)
Inventories		(711,029	)		62,256
Prepaid expenses		(580,226	)		(422,384	)
Security deposits		(17,999	)		3,751
Accounts payable and accrued expenses		119,094			226,524
Operating lease obligations		(130,828	)		(54,779	)
Customer deposits		11,377			(142,143	)
Net cash used in operating activities		(1,076,864	)		(652,506	)

Cash Flows from Investing Activities:
Purchase of property and equipment		(1,575	)		(51,669	)
Purchase of investment in digital assets		(3,248,911	)		-
Net investment in marketable securities		-			(2,755,922	)
Net cash used in investing activities		(3,250,486	)		(2,807,591	)

Cash Flows from Financing Activities:
Repayment on financing lease liabilities		(4,124	)		(12,611	)
Repayment of notes payable		(17,645	)		(41,322	)
Payment of revenue earnout		-			(2,180,826	)
Net cash used in financing activities		(21,769	)		(2,234,759	)

Net change in cash and cash equivalents		(4,349,119	)		(5,694,856	)

Cash and Cash Equivalents, Beginning of the Period		6,726,013			13,290,222

Cash and Cash Equivalents, End of the Period	$	2,376,894		$	7,595,366

Supplemental disclosures:
Cash paid for interest expense	$	6,142		$	7,930
Cash paid for income taxes	$	-		$	-

Non-Cash Investing and Financing Activities:
Common Stock issued on vesting of RSUs	$	2		$	2

See accompanying notes to the condensed consolidated financial statements

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

(1) Organization and Business Description

AmpliTech Group, Inc. (“AmpliTech” or the “Company”) was incorporated under the laws of the State of Nevada on December 30, 2010. On August 13, 2012, the Company acquired AmpliTech, Inc., by issuing 833,750 shares of the Company’s common stock to the shareholders of AmpliTech, Inc. in exchange for 100% of the outstanding shares of AmpliTech Inc. (the “Share Exchange”). After the Share Exchange, the selling shareholders owned 60,000 shares of the outstanding 893,750 shares of Company common stock, resulting in a change in control. Accordingly, the transaction was accounted for as a reverse acquisition in which AmpliTech, Inc. was deemed to be the accounting acquirer, and the operations of the Company were consolidated for accounting purposes. The capital balances have been retroactively adjusted to reflect the reverse acquisition.

AmpliTech designs, engineers and assembles microwave component based low noise amplifiers (“LNA”) that meet individual customer specifications. Application of the Company’s proprietary technology results in maximum frequency gain with minimal background noise distortion as required by each customer. The Company has both domestic and international customers in such industries as aerospace, governmental, defense and commercial satellite.

On September 12, 2019, AmpliTech Group, Inc. acquired the assets of Specialty Microwave Corporation (“Specialty”), a privately held company based in Ronkonkoma, NY. The purchase included all inventory, orders, customers, property and equipment, and all intellectual property. The assets also included all eight team members of Specialty.

Specialty designs and manufactures passive microwave components and related subsystems that meet individual customer specifications for both domestic and international customers for use in satellite communication ground networks.

On February 17, 2021, AmpliTech Group, Inc., common stock and warrants under the symbols “AMPG” and “AMPGW”, respectively, commenced trading on NASDAQ. A reverse split of the outstanding common stock at a 1-for-20 ratio became effective February 17, 2021 as of 12:01 a.m., Eastern Time. In connection with the public offering, 1,371,428 units at an offering price of $7.00 per unit were sold. Each unit issued in the offering consisted of one share of common stock and one warrant.

In 2021, the Company opened AGMDC, a monolithic microwave integrated circuits (“MMIC”) chip design center in Texas and has started to implement several of its proprietary amplifier designs into MMIC components. MMICs are semiconductor chips used in high-frequency communications applications. MMICs are widely desired for power amplification solutions to service emerging technologies, such as phased array antennas and quantum computing. MMICs carry a smaller footprint enabling them to be incorporated into a broader array of systems while reducing costs. AGMDC designs, develops and manufactures state-of-the-art signal processing components for satellite and 5G communications networks, defense, space and other commercial applications, allowing the Company to market its products to a wider base of customers requiring high technology in smaller packages.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

On November 19, 2021, AmpliTech Group, Inc. entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Spectrum Semiconductor Materials Inc. (the “Seller” or “SSM”), pursuant to which AmpliTech would acquire substantially all the assets of the Company (the “Acquisition”). The Acquisition was completed on December 15, 2021.

Spectrum Semiconductor Materials (“SSM”), located in Silicon Valley (San Jose, CA), is a global authorized distributor of integrated circuit (“IC”) packaging and lids for semiconductor device assembly, prototyping, testing, and production requirements.

In August 2022, AmpliTech Group’s True G Speed Services (AGTGSS) division was founded to serve and provide complete system integration and ORAN compliant O-RU’s (Radio Units) for telcos, enabling the industry to access ‘True 5G Speeds’. AGTGSS provides Managed Services, Cyber Security, Cloud Services, Data Sciences and Telco Cloud Services. AGTGSS will also be providing full installation of Private 5G Networks (P5G) which includes the deployment of AmpliTech Group’s developed radio units. AGTGSS will implement AmpliTech’s low noise amplifier devices in these systems to promote greater coverage, longer range and faster speeds.

(2) Loss on Investment of Digital Assets

During the three months ended March 31, 2024, the Company made several transactions in digital currency in the total amount of approximately $3.25 million. The Company believes that it was fraudulently induced to hold its digital currency with a custodian whom the Company believed to be valid, but no longer exists. The Company is taking steps in an attempt to seek recovery of the funds including discussions with local, federal, and international law enforcement agencies and private consultants and is currently conducting a review of its processes and procedures related to this investment. At the present time, the Company is not aware of, and does not expect any additional losses arising out or relating to the above described investment. In addition, the Company does not believe that the Company’s systems, records, or other assets were otherwise affected or compromised in connection with these investments.

As a result of the fraudulent digital currency transactions noted above, the Company was a victim of a cyber phishing scam that defrauded the Company. During the three months ended March 31, 2024, the Company recorded a complete loss from the investment in digital assets of $3,248,911. As of March 31, 2024, the remaining balance of digital assets was $0.

(3) Summary of Significant Accounting Policies

Basis of Accounting

The accompanying condensed consolidated financial statements have been prepared using the accrual basis of accounting.

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses for the periods presented. Actual results could differ from those estimates.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Cash and Cash Equivalents

The Company considers deposits that can be redeemed on demand and investments and marketable securities that have original maturities of less than three months, when purchased, to be cash equivalents. As of March 31, 2024 the Company’s cash and cash equivalents were deposited in four financial institutions.

The Company’s policy is to place its cash and cash equivalents with high-quality, major financial and investment institutions to limit the amount of credit exposure. Accounts at each financial institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At March 31, 2024 and December 31, 2023, the Company had $1,594,791 and $3,170,500 in excess of FDIC insured limits, respectively. The Company has not experienced any losses in such accounts.

Accounts Receivable

Accounts receivable consist of trade receivables arising from credit sales to customers in the normal course of business. These receivables are recorded at the time of sale, net of an allowance for current expected credit losses. In accordance with ASC Topic 326, “Financial Instruments – Credit Losses,” the Company estimates expected credit losses based on historical bad debt experience, the aging of accounts receivable, the current creditworthiness of our customers, prevailing economic conditions, and reasonable and supportable forward-looking information.

An allowance of $ 0 has been recorded at March 31, 2024 and December 31, 2023, respectively.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Inventories

Inventories, which consist primarily of raw materials, work in progress and finished goods, are stated at the lower of cost (first-in, first-out basis) or market (net realizable value).

Inventory quantities and related values are analyzed at the end of each fiscal quarter to determine those items that are slow moving and obsolete. An inventory reserve is recorded for those items determined to be slow moving with a corresponding charge to cost of goods sold. Inventory items that are determined obsolete are written off currently with a corresponding charge to cost of goods sold.

As of March 31, 2024 and December 31, 2023 the reserve for inventory obsolescence was $1,149,000 and $1,146,000, respectively.

Property and Equipment

Property and equipment are recorded at cost. Depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements.

Property and equipment are depreciated as follows:

Description	Useful Life	Method
Office equipment	3 to 7 years	Straight-line
Machinery/shop equipment	7 to 15 years	Straight-line
Computer equipment/software	1 to 7 years	Straight-line
Vehicles	5 years	Straight-line
Leasehold improvements	7 years	Straight-line

Intangible Assets

Definite-lived intangible assets including customer relationships and intellectual property are subject to amortization. Intangible assets are amortized over their estimated useful life on a straight-line basis. Estimated useful lives are determined considering the period the assets are expected to contribute to future cash flows. Indefinite-lived intangible assets are not subject to amortization.

Intangible assets are amortized as follows:

Schedule of Intangible Assets

Description	Useful Life	Method
Trade names	Indefinite	N/A
Customer relationships	15 to 20 years	Straight-line
Intellectual property	15 years	Straight-line

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Long-Lived Assets

The Company reviews the carrying value of long-lived assets such property and equipment, right-of-use (“ROU”) assets, and definite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Circumstances which could trigger a review include, but are not limited to; significant decrease in the market price of the asset; significant adverse changes in the business climate or legal factors; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; and current expectation that the asset will more likely than not be sold or disposed of significantly before the end of its estimated useful life.

The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of would be separately presented in the balance sheet and reported at the lower of the carrying amount of fair value less costs to sell and would no longer be depreciated. The depreciable basis of assets that are impaired and continue in use is their respective fair values. During the three months ended March 31, 2024 and the year ended December 31, 2023, there were no impairments of long-lived assets.

Goodwill and Indefinite-Lived Intangible Assets

We follow the acquisition method of accounting to record the assets and liabilities of acquired businesses at their estimated fair value at the date of acquisition. We initially record goodwill for the amount the consideration transferred exceeds the acquisition-date fair value of net tangible and identifiable intangible assets acquired.

Goodwill and intangible assets deemed to have indefinite lives are not amortized, but are tested for impairment annually on December 31, or more frequently when events or circumstances indicate an impairment may have occurred. When assessing the recoverability of goodwill and indefinite-lived intangible assets, the Company may first assess qualitative factors in determining whether it is more likely than not that the fair value of a reporting unit, including goodwill, or an indefinite-lived intangible asset is less than its carrying amount. The qualitative assessment is based on several factors, including the current operating environment, industry and market conditions, and overall financial performance. The Company may elect to bypass this qualitative assessment for some or all of its reporting units or other indefinite-lived intangible assets and perform a quantitative assessment, based on management’s judgment.

If we quantitatively test goodwill and indefinite-lived intangible assets for possible impairment, we calculate the fair value for the reporting unit and indefinite-lived assets and compare the amount to their carrying amount. If the fair value of a reporting unit and indefinite-lived asset exceeds their carrying amount, the reporting unit and indefinite-lived assets are not considered impaired. If the carrying amount of the reporting unit and indefinite-lived assets exceed their fair value, the reporting unit and indefinite-lived assets are considered to be impaired, and an impairment charge is recognized for the difference.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

We estimate the fair value of our reporting units and indefinite-lived intangible assets based on the present value of estimated future cash flows. Considerable management judgment is necessary to evaluate the impact of operating and macroeconomic changes and to estimate the future cash flows used to measure fair value. Our estimates of future cash flows consider past performance, current and anticipated market conditions and internal projections and operating plans. Additional assumptions include forecasted growth rates, estimated discount rates, and estimated royalty rates for our indefinite-lived intangible assets.

During the three months ended March 31, 2024 and the year ended December 31, 2023, there were no impairments of indefinite-lived intangible assets.

Investment Policy-Cost Method

Investments consist of non-controlling equity investments in privately held companies. The Company elected the measurement alternative for these investments without readily determinable fair values and for which the Company does not control or have the ability to exercise considerable influence over operating and financial policies. These investments are accounted for under the cost method of accounting. Under the cost method of accounting, the non-marketable equity securities are carried at cost less any impairment, adjusted for observable price changes of similar investments of the same issuer. Fair value is not estimated for these investments if there are no identified events or changes in circumstances that may influence the fair value of the investment. Under this method, the Company’s share of the earnings or losses of such investee companies is not included in the consolidated balance sheet or consolidated statements of operations. The Company held $348,250 of investments without readily determinable fair values at March 31, 2024 and December 31, 2023, respectively. (see Note 9). These investments are included in other assets on the consolidated balance sheets. There were no indicators of impairment during the three months ended March 31, 2024 and the year ended December 31, 2023.

Investment in Digital Assets

We account for all digital assets as indefinite-lived intangible assets in accordance with ASC 350, Intangibles—Goodwill and Other. The Company presents digital assets separately from other intangible assets, recorded as digital assets on the condensed consolidated balance sheets. The digital assets are initially recorded at cost and are subsequently remeasured at cost, net of any impairment losses incurred since acquisition.

We performed an analysis this quarter to identify whether events or changes in circumstances, principally decreases in the quoted prices on active exchanges, indicate that it is more likely than not that our digital assets are impaired. In determining if an impairment has occurred, we consider the lowest market price of one unit of digital asset quoted on the active exchange since acquiring the digital asset. When the then current carrying value of a digital asset exceeds the fair value determined each quarter, an impairment loss has occurred with respect to those digital assets in the amount equal to the difference between their carrying values and the prices determined. Gains are not recorded until realized upon sale(s), at which point they are presented net of any impairment losses for the same digital assets. In determining the gain to be recognized upon sale, we calculate the difference between the sales price and carrying value of the digital assets sold immediately prior to sale.

Leases

We lease property and equipment under finance and operating leases. For leases with terms greater than 12 months, we record the related asset and obligation at the present value of lease payments over the lease term. The Company has elected not to separate lease and non-lease components for all property leases for the purpose of calculating ROU assets and lease liabilities. Many of our leases include rental escalation clauses, renewal options and/or termination options that are factored into our determination of lease payments when appropriate. When available, we use the rate implicit in the lease to discount lease payments to present value; however, most of our leases do not provide a readily determinable implicit rate. Therefore, we must estimate our incremental borrowing rate to discount the lease payments based on information available at lease commencement. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow on a collateralized basis considering such factors as lease term and economic environment risks.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Revenue Recognition

We sell our products through a combination of a direct sales force in the United States and independent sales representatives in international markets. Revenue is recognized when a customer obtains control of promised goods based on the consideration we expect to receive in exchange for these goods. This core principle is achieved through the following steps:

Identify the contract with the customer. A contract with a customer exists when (i) we enter into an enforceable contract with a customer that defines each party’s rights regarding the goods to be transferred and identifies the payment terms related to these goods, (ii) the contract has commercial substance and, (iii) we determine that collection of substantially all consideration for services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. We do not have significant costs to obtain contracts with customers. For commissions on product sales, we have elected the practical expedient to expense the costs as incurred.

Identify the performance obligations in the contract. Our contracts with customers do not include multiple performance obligations to be completed over a period.

Our performance obligations relate to delivering single-use products to a customer, subject to the shipping terms of the contract. Limited warranties are provided, under which we typically accept returns and provide either replacement parts or refunds.

We do not have significant returns. We do not typically offer extended warranty or service plans.

Determine the transaction price. Payment by the customer is due under customary fixed payment terms, and we evaluate if collectability is reasonably assured. None of our contracts as of March 31, 2024 contained a significant financing component. Revenue is recorded at the net sales price, which includes estimates of variable consideration such as product returns, rebates, discounts, and other adjustments. The estimates of variable consideration are based on historical payment experience, historical and projected sales data, and current contract terms. Variable consideration is included in revenue only to the extent that it is probable that a significant reversal of the revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues.

Allocate the transaction price to performance obligations in the contract. We typically do not have multiple performance obligations in our contracts with customers. We recognize revenue upon transfer of the product to the customer’s control at contractually stated pricing.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Recognize revenue when or as we satisfy a performance obligation. We generally satisfy performance obligations at a point in time upon either shipment or delivery of goods, in accordance with the terms of each contract with the customer. We do not have significant service revenue.

Cost of Sales

We include product costs such material, direct labor, overhead costs, production-related depreciation expense, outside labor and production supplies in cost of sales.

Shipping and Handling

Shipping and handling charges are generally incurred at the customer’s expense. However, when billed to our customers, shipping and handling charges are included in net sales for the applicable period, and the corresponding shipping and handling expense is reported in cost of sales.

Research and Development

Research and development expenditures are charged to operations as incurred. The major components of research and development costs include payroll, consultants, outside service, and supplies.

Research and development costs for the three months ended March 31, 2024 and 2023 were $276,755 and $348,730, respectively.

Income Taxes

The Company’s deferred tax assets and liabilities for the expected future tax consequences of events have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statement carrying amounts and tax bases of certain assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The ASC prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The ASC provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. At March 31, 2024 and December 31, 2023, the Company had no material unrecognized tax benefits.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Earnings Per Share

Basic earnings per share (“EPS”) are determined by dividing the net earnings by the weighted-average number of shares of common shares outstanding during the period. Diluted EPS is determined by dividing net earnings by the weighted average number of common shares used in the basic EPS calculation plus the number of common shares that would be issued assuming conversion of all potentially dilutive securities outstanding under the treasury stock method. As of March 31, 2024 and 2023, there were 4,600,442 and 4,234,942, respectively, potentially dilutive shares that need to be considered as common share equivalents. As a result of the net loss, the potentially dilutive shares that need to be considered as common share equivalents, for the three months ended March 31, 2024, are anti-dilutive.

Fair Value Measurements

The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined in the following three categories:

Level 1: Unadjusted quoted prices that are available in active markets for identical assets or liabilities at the measurement date.

Level 2: Significant other observable inputs available at the measurement date, other than quoted prices included in Level 1, either directly or indirectly.

Level 3: Significant unobservable inputs that cannot be corroborated by observable market data and reflect the use of significant management judgment.

Cash and cash equivalents, receivables, inventories, prepaid expenses, accounts payable, accrued expenses, and customer deposits approximate fair value, due to their short-term nature. The carrying value of notes payable and short and long-term debt also approximates fair value since these instruments bear market rates of interest.

Assets and liabilities that are measured at fair value on a nonrecurring basis relate primarily to long-lived assets, intangible assets, and goodwill, which are remeasured when the derived fair value is below carrying value in the consolidated balance sheets.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Stock-Based Compensation

The Company records stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued and are recognized over the employees required service period, which is generally the vesting period.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash and cash equivalents, marketable securities and accounts receivable.

The Company places its cash and cash equivalents and marketable securities with high-quality, major financial and investment institutions in order to limit the amount of credit exposure. For accounts receivable, the Company performs ongoing credit evaluations of its customers and maintains allowances for potential credit losses.

Recent Issued Accounting Pronouncements

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances the transparency and decision usefulness of income tax disclosures by requiring; (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2025, with early adoption permitted. These amendments are to be applied prospectively, with retrospective application permitted. We are currently evaluating the impact this standard will have on our consolidated financial statement disclosures.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires a public entity to disclose significant segment expenses and other segment items on an annual and interim basis and to provide in interim periods all disclosures about reportable segment’s profit or loss and assets that are currently required annually. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. These amendments are to be applied retrospectively. We are currently evaluating the impact this standard will have on our consolidated financial statement disclosures.

In August 2023, the FASB issued ASU 2023-05, Business Combinations—Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement, which requires a newly-formed joint venture to apply a new basis of accounting to its contributed net assets, resulting in the joint venture initially measuring its contributed net assets at fair value on the formation date. ASU 2023-05 is effective for all joint venture formations with a formation date on or after January 1, 2025, with early adoption permitted. These amendments are to be applied prospectively, with retrospective application permitted for joint ventures formed before the effective date. We are currently evaluating the impact this standard will have on our consolidated financial statement disclosures.

(4) Revenues

The following table presents sales disaggregated based on geographic regions and for the three months ended:

Schedule of disaggregated revenue

	March 31, 2024		March 31, 2023
AmpliTech Inc. and Specialty Microwave
Domestic sales	$	678,182	$	1,024,245
International sales		362,685		197,954
Total sales	$	1,040,867	$	1,222,199

Spectrum
Domestic sales	$	781,007	$	1,877,693
International sales		471,457		1,012,407
Total sales	$	1,252,464	$	2,890,100

Total sales		2,293,331	$	4,112,299

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

(5) Segment Reporting

ASC 280, “Segment Reporting”, establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organizational structure as well as information about geographical areas, business segments and major customers in financial statements for details on the Company’s business segments. The Company has two reportable segments, the manufacturing and engineering segment, which is operated by AmpliTech Inc. and Specialty Microwave: and the distribution segment, which is operated by Spectrum. The manufacturing and engineering segment assembles microwave components, and the distribution segment is a global distributor of integrated circuits packages and lids. The Company provides general corporate services to its segments; however, these services are not considered when making operating decisions and assessing segment performance. These services are reported under “Corporate” below and include costs associated with executive management, financing activities and public company compliance.

The following table presents summary information by segment for the three months ended March 31, 2024:

Schedule of Segment Reporting

	AmpliTech Inc. And Specialty			Spectrum			Corporate			Total
Revenue	$	1,040,867		$	1,252,464			-		$	2,293,331
Cost of Goods Sold		775,471			635,230			-			1,410,701
Net Loss		(1,004,973	)		(48,947	)		(3,601,241	)		(4,655,161	)
Total Assets		10,980,634			15,386,131			502,234			26,868,999
Depreciation and Amortization		100,201			28,922			-			129,123
Interest Expense, net		1,680			-			2,663			4,343

The following table presents summary information by segment for the three months ended March 31, 2023:

	AmpliTech Inc. And Specialty			Spectrum			Corporate			Total
Revenue	$	1,222,199		$	2,890,100			-		$	4,112,299
Cost of Goods Sold		760,179			1,535,589			-			2,295,768
Net Income (Loss)		(1,009,532	)		720,854			(293,288	)		(581,966	)
Total Assets		13,870,908			16,946,958			3,140,686			33,958,552
Depreciation and Amortization		82,175			32,270			-			114,445
Interest Income (Expense), net		16,939			(75	)		(3,093	)		13,771

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

(6) Inventories

The inventory consists of the following at March 31, 2024 and December 31, 2023:

Schedule of Inventory

	March 31, 2024			December 31, 2023

Raw Materials	$	1,252,168		$	959,645
Work-in Progress		79,608			51,140
Finished Goods		7,062,832			6,672,793
Subtotal	$	8,394,607		$	7,683,578
Less: Reserve for Obsolescence		(1,149,000	)		(1,146,000	)

Total	$	7,245,607		$	6,537,578

(7) Property and Equipment

Property and Equipment consisted of the following at March 31, 2024 and December 31, 2023:

Schedule of Property and Equipment

	March 31, 2024			December 31, 2023

Lab Equipment	$	3,400,207		$	3,400,207
Manufacturing Equipment		129,745			129,745
Automobiles		7,335			7,335
Computer Equipment and Software		195,813			194,238
Leasehold Improvements		84,172			84,172
Furniture and Fixtures		170,643			170,643

Subtotal		3,987,915			3,986,340
Property plant and equipment, gross		3,987,915			3,986,340
Less: Accumulated Depreciation		(1,478,550	)		(1,386,892	)

Total	$	2,509,365		$	2,599,448
Property plant and equipment, net	$	2,509,365		$	2,599,448

Depreciation expense for the three months ended March 31, 2024 and 2023 was $91,658 and $77,092 respectively, of which $71,124 and $57,894, respectively were included in cost of goods sold.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Property and equipment purchased in the amount of $234,036 under financing leases is included in the totals above. As of March 31, 2024 and 2023, the outstanding balance of the financing leases were $45,212 and $70,205, respectively.

(8) Goodwill and Intangible Assets

Goodwill

Goodwill is related to the acquisition of Spectrum Semiconductor Materials Inc. on December 15, 2021. Goodwill is primarily related to expected improvements and technology performance and functionality, as well as sales growth from future product and service offerings and new customers, together with certain intangible assets that do not qualify for separate recognition. Goodwill is generally not amortizable for tax and financial statement purposes. As of March 31, 2024 and December 31, 2023, goodwill was $4,696,883, respectively.

Other Intangible Assets

Intangible assets with an estimated useful life of fifteen and twenty years consisted of the following at March 31, 2024:

Schedule of Intangible Assets

	Gross Carrying		Accumulated				Weighted
	Amount		Amortization		Net		Average Life
Trade name	$	584,517	$	-	$	584,517		Indefinite
Customer relationships		2,591,491		370,426		2,221,065		16.56
Intellectual Property		202,771		61,685		141,086		10.46

Total	$	3,378,779	$	432,111	$	2,946,668

Amortization expense for the three months ended March 31, 2024 and 2023 was $37,465 and $37,353, respectively.

Annual amortization of intangible assets are as follows:

Schedule of Amortization of Assets


2024		112,508
2025		149,974
2026		149,974
2027		149,974
2028		149,974
Thereafter		1,649,747
Total	$	2,362,151

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

(9) Cost Method Investment

On June 10, 2021, the Company entered into a membership interest purchase agreement with SN2N, LLC for an aggregate purchase price of $350,000, to be paid in four tranches. Each tranche represented a 5% membership interest, and in aggregate a 20% membership interest. On June 15, 2022, an amendment to the membership interest purchase agreement was made to reflect a 19.9% membership interest. In light of this amendment, the Company overpaid $1,750 for the membership interest and was subsequently reimbursed. As of March 31, 2024, the Company has made an investment of $348,250 for a 19.9% membership interest.

(10) Leases

The following was included in our balance sheet as of March 31, 2024:

	March 31, 2024
Operating leases
Assets
ROU operating lease assets	$	3,403,891

Liabilities
Current portion of operating lease	$	495,595
Operating lease, net of current portion	$	3,086,880
Total operating lease liabilities	$	3,582,475

Financing leases
Assets
Property and equipment, gross	$	234,036
Accumulated depreciation		(161,494	)
Property and equipment, net	$	72,542

Liabilities
Current portion of financing lease	$	17,003
Financing lease, net of current portion	$	28,209
Total financing lease liabilities	$	45,212

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

The weighted average remaining lease term and weighted average discount rate at March 31, 2024 are as follows:

Weighted average remaining lease term (years)	March 31, 2024
Operating leases		9.28
Financing leases		2.74
Weighted average discount rate
Operating leases		4.46	%
Financing leases		4.71	%

Financing Lease

The Company entered into several 60-month lease agreements to finance certain laboratory and office equipment. As such, the Company has accounted for these transactions as a financing lease.

The following table reconciles future minimum financing lease payments to the discounted lease liability as of March 31, 2024:


2024		14,070
2025		18,195
2026		11,982
2027		3,994
Total lease payments		48,241
Less imputed interest		(3,029	)
Total lease obligations		45,212
Less current obligations		(17,003	)
Long-term lease obligations	$	28,209

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Operating Leases

On September 12, 2019, the Company entered into a new operating lease agreement to rent office space in Ronkonkoma, NY. This five- year agreement commenced on September 12, 2019 with an annual rent of $90,000 and 3% increase in each successive lease year beginning in 2021. The Company has an option to buy the property during the first two years of the lease for $1,200,000 and then at fair market value for the remainder of the lease term. This option has expired and was not exercised as of December 31, 2022. On April 13, 2023, this lease was terminated subject to the terms of a Surrender Agreement between the Company and landlord. As a result, a gain on termination of right-of-use operating lease was recognized of $8,461.

On November 27, 2019, the Company entered a 39-month agreement to lease an automobile with a monthly payment of $420. This lease was paid in full as of March 31, 2023.

On December 15, 2021, the Company assumed the SSM lease agreement for office and warehouse space in San Jose, CA, with the same terms and conditions. Effective February 1, 2020, the lease term will expire on January 31, 2025 with a base rent of $24,234 for the first 12 months and increase by approximately 3% every year.

On October 15, 2021, the Company entered a new lease for a 20,000 square foot facility at 155 Plant Avenue, Hauppauge, New York, for a term of seven years and two months. The yearly base rent of $346,242 shall increase at a rate of 2.75% per year to begin on the first anniversary lease commencement date and each year thereafter. The first two months of basic rent shall be abated following the commencement lease date. In the event the landlord decides to sell the property, the Company shall have the right of first offer to purchase subject property. Upon lease execution, the Company paid two months of base rent as a security deposit and one month’s rent totaling $86,560. The Company moved into the new manufacturing and headquarters facility April 1, 2022.

On August 9, 2023, the Company entered a 39-month agreement for $20,880 to lease an automobile with a monthly payment of $605.

On January 15, 2024, the Company entered a triple net lease agreement for a 1,900 square foot facility in Allen, Texas for a term of five years and one month. The yearly base rent of $53,675 shall increase at a rate of 2.5% per year to begin on the first anniversary lease commencement date and each year thereafter. The first month’s rent shall be abated following the commencement lease date. Upon lease execution, the Company paid two months of rent as a security deposit and one month’s rent totaling $17,999. As of March 31, 2024, the new MMIC division facility lease had not yet commenced, as the Company did not have the right to obtain substantially all the economic benefits from the use of the asset or the right to direct the use of the asset. The Company expects to commence the new facility lease on or near August 1, 2024.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

The following table reconciles future minimum operating lease payments to the discounted lease liability as of March 31, 2024:


2024		524,712
2025		407,580
2026		389,397
2027		393,899
2028		404,721
Thereafter		2,313,460
Total lease payments		4,433,770
Less imputed interest		(851,295	)
Total lease obligations		3,582,475
Less current obligations		(495,595	)
Long-term lease obligations	$	3,086,880

(11) Notes Payable

Promissory Note:

On September 12, 2019, AmpliTech Group, Inc. acquired Specialty, a privately held company based in Ronkonkoma, NY. The purchase included all inventory, orders, customers, property and equipment, and all intellectual property. The assets also included all eight team members of Specialty. The total consideration paid was $1,143,633, consisting of $668,633 in cash and a $475,000 promissory note with an interest rate of 6%. Beginning November 1, 2019, payment of principal and interest shall be due payable in fifty-nine (59) monthly payments of $9,213 with a final payment due October 1, 2024 of $9,203. As of March 31, 2024, the balance of this promissory note was $63,196. Principal payments of $17,645 along with interest expense of $782 was paid during the three months ended March 31, 2024.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Loan Payable:

On September 12, 2019, the Company was approved for a $250,000 equipment leasing facility which was subsequently increased to $500,000. The Company has borrowed against the leasing facility as follows:

	●	On May 14, 2020, the Company borrowed $27,494 to be paid over a three-year term with monthly payments of $815 at an interest rate of 4.27%. The balance as of March 31, 2024 and 2023 was $0 and $812, respectively. Principal payments of $0 and $2,418, were paid for the three months ended March 31, 2024 and 2023, respectively. Total interest expense paid for the three months ended March 31, 2024 and 2023 was $0 and $27, respectively. This loan was paid in full in April 2023.

	●	On June 10, 2020, the Company borrowed $41,015 to be paid over a three-year term with monthly payments of $1,216 at an interest rate of 4.28%. The balance as of March 31, 2024 and 2023 was $0 and $2,418, respectively. Principal payments of $0 and $3,593 were made for the three months ended March 31, 2024 and 2023, respectively. Total interest expense paid for the three months ended March 31, 2024 and 2023 was $0 and $55, respectively. This loan was paid in full in May 2023.

As of March 14, 2023, the Company closed the equipment line of credit of $500,000, which had $0 balance. All UCC filings on the Company assets have been released as well as the President’s personal guarantee.

In January 2022, the Company purchased machinery for $91,795, applying a deposit of $9,180 and financing the balance of $82,616 over 24 payments at an interest rate of 1.90%. The balance as of March 31, 2024 and 2023 was $0 and $31,349, respectively. Principal payments of $0 and $10,351 and interest expense of $0 and $182 were paid for the three months ended March 31, 2024 and 2023, respectively.

Future principal payments over the term of the loans as of March 31, 2024 are as follows:

	Payments
2024	$	63,196
Total remaining payments	$	63,196

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

(12) Stockholders’ Equity

The total number of shares of stock this Corporation is authorized to issue shall be five hundred one million (501,000,000) shares, par value $0.001 per share. Our authorized capital stock consists of 500,000,000 shares of common stock and 1,000,000 shares of blank check preferred stock.

Preferred Stock

On July 10, 2013, the Board of Directors of the Company approved a certificate of amendment to the articles of incorporation and changed the authorized capital stock of the Company to include and authorize 500,000 shares of Preferred Stock, par value $0.001 per share. On October 7, 2020, the Board of Directors of the Company approved a certificate of amendment to the articles of incorporation and changed the total number of authorized shares of Preferred Stock to 1,000,000 shares, $0.001 per share.

On October 7, 2020, our Board of Directors and our stockholders approved a resolution to amend and restate the certificate of designation of preferences, rights and limitations of Series A Convertible Preferred Stock to restate that there are 401,000 shares of the Company’s blank check Preferred Stock designated as Series A Convertible Preferred Stock. The amended and restated certificate clarifies that the Series A Convertible Preferred Stock convert at a rate of five shares of the Company’s common stock for every share of Series A Convertible Preferred Stock, and also restates that the Series A Convertible Preferred Stock shall be entitled to vote on all matters submitted to shareholders of the Company for each share of Series A Convertible Preferred Stock owned on the record date for the determination of shareholders entitled to vote on such matter or, if no such record date is established, on the date such vote is taken, or any written consent of shareholders is solicited. The number of votes entitled to be cast by the holders of the Series A Convertible Preferred Stock equals that number of votes that, together with votes otherwise entitled to be cast by the holders of the Series A Convertible Preferred Stock at a meeting, whether by virtue of stock ownership, proxies, voting trust agreements or otherwise, entitle the holders to exercise 51% of all votes entitled to be cast to approve any action which Nevada law provides may or must be approved by vote or consent of the holders of common stock entitled to vote.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Common Stock:

The Company originally authorized 50,000,000 shares of common stock with a par value of $0.001. Effective May 20, 2014, the Company increased its authorized shares of common stock from 50,000,000 to 500,000,000.

On February 17, 2021, AmpliTech Group Inc., common stock and warrants under the symbols “AMPG” and “AMPGW”, respectively, commenced trading on NASDAQ.

2020 Equity Incentive Plan:

In October 2020, the Board of Directors and shareholders adopted the Company’s 2020 Equity Incentive Plan (the “2020 Plan”), effective as of December 14, 2020. Under the 2020 Plan, the Company reserved 1,250,000 shares of common stock to grant shares of the Company’s common stock to employees and individuals who perform services for the Company. The purpose of the 2020 Plan is to attract and retain the best available personnel for positions of substantial responsibility, to provide incentives to individuals who perform services for the Company, and to promote the success of the Company’s business. The 2020 Plan permits the grant of Incentive Stock Options, Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Units, Performance Shares, and other stock or cash awards as the Board of Directors may determine.

In 2023, the Board and the shareholders adopted the Company’s Amended and Restated 2020 Equity Incentive Plan (the “Amended and Restated Plan”), effective as of December 11, 2023. The Amended and Restated Plan is substantially similar to the 2020 Plan except that it increases the shares of our common stock available for issuance thereunder to 2,250,000 shares of common stock.

Stock Options:

On January 9, 2024, the Company granted a consultant, ten-year stock options to purchase 2,500 shares of common stock according to the Company’s 2020 Plan. The stock options vested immediately, with an exercise price of $1.86 per share. The Company has calculated these options estimated fair market value at $3,800 using the Black-Scholes model, with the following assumptions: expected term of 5.00 years, stock price of $1.86, exercise price of $1.86, volatility of 116.1%, risk-free rate of 3.97%, and no forfeiture rate.

On January 16, 2024, the Company granted an employee ten-year stock options to purchase 5,000 shares of common stock according to the Company’s 2020 Plan. The stock options vest in equal quarterly installments over five years commencing on April 16, 2024, with an exercise price of $1.93 per share. The Company has calculated these options estimated fair market value at $8,800 using the Black-Scholes model, with the following assumptions: expected term of 7.51 years, stock price of $1.93, exercise price of $1.93, volatility of 120.1%, risk-free rate of 4.01%, and no forfeiture rate.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

On January 16, 2024, the Company granted an independent contractor ten-year stock options to purchase 50,000 shares of common stock according to the Company’s 2020 Plan. 20,000 stock options vested immediately and the balance of 30,000 shall vest in equal quarterly installments over three years commencing on June 30, 2024, with an exercise price of $2.19 per share. The Company has calculated these options estimated fair market value at $98,600 using the Black-Scholes model, with the following assumptions: expected term of 10.00 years, stock price of $2.19, exercise price of $2.19, volatility of 123.0%, risk-free rate of 4.07%, and no forfeiture rate.

Below is a table summarizing the changes in stock options outstanding for the three months ended March 31, 2024:

Schedule of Stock Options Outstanding

	Number of		Weighted Average
	Options		Exercise Price ($)
Outstanding at December 31, 2023		1,236,000	$	2.30
Granted		57,500	$	2.15
Exercised		-		-
Expired		-		-
Outstanding at March 31, 2024		1,293,500	$	2.30
Exercisable at March 31, 2024		553,953	$	2.83

As of March 31, 2024, all outstanding stock options were issued according to the Company’s 2020 Plan, and there remains 811,500 shares of common stock available for future issuance under the 2020 Plan.

Stock-based compensation expense related to stock options of $133,786 was recorded for the three months ended March 31, 2024. As of March 31, 2024, the remaining unrecognized compensation cost related to non-vested stock options is $1,232,708 and is expected to be recognized over 4.80 years. The outstanding stock options have a weighted average remaining contractual life of 5.22 years and a total intrinsic value of $61,450.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Warrants:

Effective February 19, 2021, AmpliTech Group Inc., common stock and warrants under the symbols “AMPG” and “AMPGW,” respectively, commenced trading on NASDAQ. In connection with the public offering, 1,371,428 units sold at an offering price of $7.00 per unit. Each unit issued in the offering consisted of one share of common stock and one warrant. Maxim Group LLC acted as sole book-running manager for the offering. The warrants expire ten years from the date of issuance.

Maxim Group LLC acted as sole book-running manager for the offering and partially exercised its overallotment option to purchase 205,714 warrants at the public offering price. The warrants expire ten years from the date of issuance.

Effective April 16, 2021, the Company entered into definitive agreements with certain institutional investors to sell 2,715,000 shares of common stock in a registered direct offering priced at the market under NASDAQ rules. Concurrently, the Company agreed to issue to the investors, in a private placement, warrants to purchase an aggregate of 1,900,500 shares of common stock at an exercise price of $8.48 per share with a five-year term.

On July 20, 2021, in connection with a product development agreement with an unrelated party, the Company issued warrants to purchase 30,000 shares of common stock. The warrants vest one year from issuance, with an exercise price of $5.00 per share. The Company has calculated these warrants estimated fair market value at $88,803 using the Black-Scholes model, with the following assumptions: expected term 3.0 years, stock price $3.80, exercise price $5.00, volatility 149.8%, risk-free rate 0.37%, and no forfeiture rate.

Below is a table summarizing the changes in warrants outstanding for the three months ended March 31, 2024:

Schedule of Warrants Outstanding

	Number of		Weighted Average
	Warrants		Exercise Price ($)
Outstanding at December 31, 2023		3,296,942	$	7.83
Granted		-		-
Exercised		-		-
Expired		-		-
Outstanding at March 31, 2024		3,296,942	$	7.83
Exercisable at March 31, 2024		3,296,942	$	7.83

Stock-based compensation expense related to warrants of $0 was recorded for the three months ended March 31, 2024. As of March 31, 2024, the remaining unrecognized compensation cost related to non-vested warrants is $0. The outstanding warrants have a weighted average remaining contractual life of 2.23 years and a total intrinsic value of $0.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Restricted Stock Units:

On May 20, 2022, 30,000 restricted stock units at an exercise price of $1.96 were issued to a board advisor. Vesting will occur in equal quarterly installments of 2,500 shares beginning on May 20, 2022. As of March 31, 2024, 12,500 shares of common stock were issued.

Below is a table summarizing the changes in restricted stock units outstanding for the three months ended March 31, 2024:

	Number of			Weighted Average
	RSU’s			Exercise Price ($)
Outstanding at December 31, 2023		12,500			1.96
Granted		-			-
Exercised		(2,500	)	$	1.96
Expired		-			-
Outstanding at March 31, 2024		10,000		$	1.96
Exercisable at March 31, 2024		-			-

Stock-based compensation expense related to restricted stock units of $4,871 was recorded for the three months ended March 31, 2024. As of March 31, 2024, the remaining unrecognized compensation cost related to non-vested restricted stock units is $22,374. The outstanding restricted stock units have a weighted average remaining contractual life of .89 years and a total intrinsic value of $0.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion provides information which management believes is relevant to an assessment and understanding of our results of operations and financial condition. The discussion should be read along with our financial statements and notes thereto contained elsewhere in this Quarterly Report on Form 10-Q. The following discussion and analysis contain forward-looking statements, which involve risks and uncertainties. Our actual results may differ significantly from the results, expectations and plans discussed in these forward-looking statements.

Business Overview

AmpliTech Group Inc. (“AMPG,” “AmpliTech” or the “Company”), incorporated in 2010 in the state of Nevada, is the parent company of its subsidiary, AmpliTech, Inc., and the Company’s divisions Specialty Microwave, Spectrum Semiconductor Materials, AmpliTech Group MMIC Design Center (“AGMDC”) and AmpliTech Group True G Speed Services (‘AGTGSS”).

AmpliTech designs, engineers, and assembles microwave component-based low noise amplifiers (“LNA”) that meet individual customer specifications. Application of the Company’s proprietary technology results in maximum frequency gain with minimal background noise distortion as required by each customer. The Company has both domestic and international customers in such industries as aerospace, governmental, defense, and commercial satellite.

AGMDC designs, develops and manufactures state-of-the-art signal processing components for satellite and 5G communications networks, defense, space and other commercial applications, allowing the Company to market its products to wider base of customers requiring high technology in smaller packages.

In August 2022, we formed our AGTGSS division to enable “true G speeds” to the industry. AGTGSS’ main function will be to plan and configure 5G radio systems and make them O-RAN compliant. AGTGSS will implement AmpliTech’ s low noise amplifier devices in these systems to promote greater coverage, longer range and faster speeds.

Our mission is to patent our proprietary IP and trade secrets that were used in small volume niche markets and expand our capabilities through strategic partnerships, joint ventures, mergers/acquisitions with key industry leaders in the 5G/6G, quantum computing, and cybersecurity markets. We believe this will enable us to scale up our products and revenue by developing full systems and subsystems with our unique technology as a core component, which we expect will position us as a global leader in these rapidly emerging technology sectors and addresses large volume markets as well, such as cellphone handsets, laptops, server networks, and many other applications that improve everyday quality of life.

The Company’s research and development initiative to expand its product line of low noise amplifiers to include its new 5G and wireless infrastructure products and MMIC designs is progressing significantly. Our combined engineering and manufacturing resources are expected to complement the development of new subsystems for satellite, wireless, and 5G infrastructure, as well as advanced military and commercial markets.

Loss on Investment of Digital Assets

Corporate Information

Our principal executive offices are located at 155 Plant Avenue, Hauppauge, NY 11788. Our telephone number is (631) 521-7831. Our corporate website is www.amplitechinc.com. The information on our website is not a part of, or incorporated in, this prospectus.

Results of Operations

For the Three Months Ended March 31, 2024 and March 31, 2023

Revenues

Sales decreased from $4,112,299 for the three months ended March 31, 2023, to $2,293,331 for the three months ended March 31, 2024, a decrease of $1,818,968 or approximately 44.23%. Sales in the amplifier and related passive microwave components and subsystems division decreased by $181,332, or 14.84%. Spectrum sales decreased by $1,637,636, or 56.67%, a decline attributable to a decrease in sales from domestic and international customers, specifically in the Asian markets.

Cost of Goods Sold and Gross Profit

Cost of goods sold decreased from $2,295,768 for the three months ended March 31, 2023, to $1,410,701 for the three months ended March 31, 2024, a decrease of $885,067 or 38.55%. Overall, this decrease is directly related to the decline in sales. As a result, gross profit was $882,630 for the three months ended March 31, 2024, compared to $1,816,531 for the three months ended March 31, 2023, a decrease of $933,901, or 51.41%. Gross profit as a percentage of sales decreased to 38.49% from 44.17%, as a result of decreased sales, and the product mix shipped this quarter having a lower gross profit margin.

Selling, General and Administrative Expenses

Selling, general and administrative expenses decreased to $2,033,747 for the three months ended March 31, 2024, from $2,086,912 for the first three months ended March 31, 2023, a decrease of $53,165 or approximately 2.55%.

Research and Development Expenses

Research and development expenditures are charged to operations as incurred. The major components of research and development costs include salaries and benefits, consultants, outside service, and supplies.

Research and development costs for the three months ended March 31, 2024, and 2023, were $276,755 and $348,730, respectively, a decrease of $71,975, or 20.64%, resulting from the decrease in consulting expense.

Loss From Operations

As a result of the above, the Company reported a loss from operations of $1,472,872 and $619,111 for the three months ended March 31, 2024, and 2023, respectively.

Other Income (Expenses)

The Company recorded interest expense, net of $4,343 and interest income, net of $13,771 for the three months ended March 31, 2024, and 2023.

Due to market fluctuations, the Company recorded an unrealized gain on investments of $18,546 for the three months ended March 31, 2023, and a realized gain on investments of $25,965 and $4,828 for the three months ended March 31, 2024 and 2023, respectively. Additionally, as a result of the fraudulent digital current transactions noted above, during the three months ended March 31, 2024, the Company recorded an impairment loss of $3,248,911 related to its digital assets.

Net Income (Loss)

As a result of the items listed above, the Company reported a net loss of $4,655,161 and $581,966 for the three months ended March 31, 2024 and 2023.

Liquidity and Capital Resources

Operating Activities

The net cash used in operating activities for the three months ended March 31, 2024, was $1,076,864 resulting primarily from the net loss and operating changes in accounts receivable, inventories, prepaid expenses, accounts payable and accrued expenses customer deposits and operating lease liability.

The net cash used in operating activities for the three months ended March 31, 2023, was $652,506 resulting primarily from the net loss and operating changes in accounts receivable, prepaid expenses, operating lease liability, and customer deposits.

Investing Activities

The net cash used in investing activities for the three months ended March 31, 2024, was $3,250,486 for the purchase of equipment and investment in digital assets.

The net cash used in investing activities for the three months ended March 31, 2023, was $2,807,591, of which $51,669 related to the purchase of equipment and $2,755,922 for the purchase of marketable securities.

Financing Activities

The net cash used in financing activities for the three months ended March 31, 2024, was $21,769, resulting primarily from the repayments of notes payable and financing lease liabilities.

The net cash used in financing activities for the three months ended March 31, 2023, was $2,234,759, resulting primarily from the repayments of notes payable, financing lease liabilities, and the revenue earnout.

As of March 31, 2024, we had cash and cash equivalents of $2,376,894, working capital of $11,287,779, and an accumulated deficit of $14,424,884.

As of December 31, 2023, we had cash and cash equivalents of $6,726,013, working capital of $15,649,254, and an accumulated deficit of $9,769,723.

We intend to continue to finance our internal growth with cash on hand, cash provided from operations, borrowings, debt or equity offerings, or some combination thereof. We believe that our cash to be provided from operations, cash on hand, and our current working capital, will be sufficient to fund our operations for the next twelve months.

Critical Accounting Policies, Estimates and Assumptions

The SEC defines critical accounting policies as those that are, in management’s view, most important to the portrayal of our financial condition and results of operations and those that require significant judgment and estimates.

The discussion and analysis of our financial condition and results of operations is based upon financial statements which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities. On an on-going basis, we evaluate our estimates, including the allowance for doubtful accounts, the salability and recoverability of inventory, income taxes and contingencies. We base our estimates on historical experience and on other assumptions that we believe to be reasonable under the circumstances, the results of which form our basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The Company believes there have been no significant changes during the three month period ended March 31, 2024, to the items disclosed as critical accounting policies in management’s discussion and analysis in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

We cannot predict what future laws and regulations might be passed that could have a material effect on our results of operations. We assess the impact of significant changes in laws and regulations on a regular basis and update the assumptions and estimates used to prepare our financial statements when we deem it necessary.

Off Balance Sheet Transactions

None.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Smaller reporting companies are not required to provide the information required by this item.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Our management, including our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Exchange Act as of the end of the period covered by this report. Our management does not expect that our disclosure controls and procedures will prevent all error and all fraud. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

Based on that evaluation, as of March 31, 2024, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were not effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

We regularly review our internal controls over financial reporting and make changes to our processes and systems to improve controls and increase efficiency, while ensuring that we maintain an effective internal control environment. Changes may include such activities as implementing new, more efficient systems, consolidating activities, and migrating processes.

During its evaluation of the effectiveness of our internal control over financial reporting as of March 31, 2024, our management identified the following material weaknesses:

	●	we do not have written documentation of our internal control policies and procedures, including written policies and procedures to ensure the correct application of accounting and financial reporting with respect to the current requirements of GAAP and SEC disclosure requirements;

	●	we failed to maintain a sufficient complement of personnel in our accounting and reporting department to ensure adequate segregation of duties such that appropriate review and monitoring of its financial records are executed;

	●	we failed to maintain sufficient segregation of duties and approval hierarchy for material transactions and cash disbursements, specifically, there was a lack of segregation of duties involved in the execution and approvals of wire transfers for material investments in digital assets;

	●	we did not design and maintain effective internal controls related to our information technology general controls in the areas of user access and program change-management over certain information technology systems that support our financial reporting processes; and

	●	we failed to understand and consistently follow proper corporate procedures.

As disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, our management has identified certain steps necessary to address the material weaknesses, and in the first and second quarter of 2024, we continued to implement the following remedial procedures:

	●	increasing personnel resources and technical accounting expertise within the accounting function;

	●	until we have sufficient technical accounting resources, we have engaged external consultants to provide support and to assist us in our evaluation of more complex applications of GAAP;

	●	engaging internal control consultants to assist us in performing a financial reporting risk assessment as well as identifying and designing our system of internal controls necessary to mitigate the risks identified;

	●	preparation of written documentation of our internal control policies and procedures and accounting processes;

	●	requiring an approval hierarchy for all material expenses and transactions, which we implemented in the second quarter of 2024; and

	●	commencing in the second quarter of 2024, requiring dual authorization on all ACH payments and bank wires, including an appropriate approval hierarchy, including board approval, on material transactions and agreements or any investment of Company funds.

We will continue to enhance corporate oversight over process-level controls and structures to ensure that there is appropriate assignment of authority, responsibility, and accountability to enable remediation of our material weaknesses. We believe that our remediation plan will be sufficient to remediate the identified material weaknesses and strengthen our internal control over financial reporting. As we continue to evaluate, and work to improve, our internal control over financial reporting, management may determine that additional measures to address control deficiencies or modifications to the remediation plan are necessary.

Other than the changes and remedial measures described above, there were no other changes in our internal controls over financial reporting during the first quarter of 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1. Legal Proceedings.

To the best of our knowledge, there are no pending legal proceedings to which we are a party or of which any of our property is the subject.

Item 1A. Risk Factors.

We have concluded that there are material weaknesses in our internal control over financial reporting, which, if not remediated, could materially adversely affect our ability to timely and accurately report our results of operations and financial condition. The accuracy of our financial reporting depends on the effectiveness of our internal controls over financial reporting.

Internal controls over financial reporting can provide only reasonable assurance with respect to the preparation and fair presentation of financial statements and may not prevent or detect misstatements. Failure to maintain effective internal controls over financial reporting, or lapses in disclosure controls and procedures, could undermine the ability to provide accurate disclosure (including with respect to financial information) on a timely basis, which could cause investors to lose confidence in the Company’s disclosures (including with respect to financial information), require significant resources to remediate the lapse or deficiency, and expose it to legal or regulatory proceedings.

During its evaluation of the effectiveness of our internal control over financial reporting as of March 31, 2024, our management identified the following material weaknesses:

	●	we do not have written documentation of our internal control policies and procedures, including written policies and procedures to ensure the correct application of accounting and financial reporting with respect to the current requirements of GAAP and SEC disclosure requirements;

	●	we failed to maintain a sufficient complement of personnel in our accounting and reporting department to ensure adequate segregation of duties such that appropriate review and monitoring of its financial records are executed;

	●	we failed to maintain sufficient segregation of duties and approval hierarchy for material transactions and cash disbursements, specifically, there was a lack of segregation of duties involved in the execution and approvals of wire transfers for material investments in digital assets;

	●	we did not design and maintain effective internal controls related to our information technology general controls in the areas of user access and program change-management over certain information technology systems that support our financial reporting processes; and

	●	we failed to understand and consistently follow proper corporate procedures.

The Company’s remediation efforts are ongoing and the Company is implementing the following remedial procedures:

	●	increasing personnel resources and technical accounting expertise within the accounting function;

	●	until we have sufficient technical accounting resources, we have engaged external consultants to provide support and to assist us in our evaluation of more complex applications of GAAP;

	●	engaging internal control consultants to assist us in performing a financial reporting risk assessment as well as identifying and designing our system of internal controls necessary to mitigate the risks identified;

	●	preparation of written documentation of our internal control policies and procedures and accounting processes;

	●	requiring an approval hierarchy for all material expenses and transactions, which we implemented in the second quarter of 2024; and

	●	commencing in the second quarter of 2024, requiring dual authorization on all ACH payments and bank wires, including an appropriate approval hierarchy, including board approval, on material transactions and agreements or any investment of Company funds.

We cannot guarantee that we will be successful in remediating the material weakness identified or that our internal control over financial reporting, as modified, will enable us to identify or avoid material weaknesses in the future.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable

Item 5. Other Information.

None.

Item 6. Exhibits.

(a) Exhibits

*Exhibit No.*		*Description*
31.1		Rule 13a-14(a)/ 15d-14(a) Certification of Principal Executive Officer
31.2		Rule 13a-14(a)/ 15d-14(a) Certification of Principal Financial Officer
32.1		Section 1350 Certification of Principal Executive Officer
32.2		Section 1350 Certification of Principal Financial Officer
101. INS		Inline XBRL Instance Document
101. SCH		Inline XBRL Taxonomy Extension Schema Document
101. CAL		Inline XBRL Taxonomy Extension Calculation Link base Document
101. DEF		Inline XBRL Taxonomy Extension Definition Link base Document
101. LAB		Inline XBRL Taxonomy Extension Label Link base Document
101. PRE		Inline XBRL Taxonomy Extension Presentation Link base Document
104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	AmpliTech Group, Inc.

Date: May 28, 2024	By:	/s/ Fawad Maqbool
		Fawad Maqbool
		President and Chief Executive Officer (Principal Executive Officer)

Date: May 28, 2024

By:

/s/ Louisa Sanfratello

Louisa Sanfratello

Chief Financial Officer

(Principal Financial and Accounting Officer)

EXHIBIT 31.1

CERTIFICATION OF

PRINCIPAL EXECUTIVE OFFICER PURSUANT TO

SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

I, Fawad Maqbool, certify that:

1.	I have reviewed the quarterly report on Form 10-Q of AmpliTech Group, Inc.(the “registrant”) for the quarter ended March 31, 2024;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer(s), and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s), and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b.	Any fraud, whether material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: May 28, 2024

By:

/s/ Fawad Maqbool

Fawad Maqbool

President and Chief Executive Officer

(Principal Executive Officer)

EXHIBIT 31.2

CERTIFICATION OF

PRINCIPAL FINANCIAL OFFICER PURSUANT TO

SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

I, Louisa Sanfratello, certify that:

1.	I have reviewed the quarterly report on Form 10-Q of AmpliTech Group, Inc. (the “registrant”) for the quarter ended March 31, 2024;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer(s), and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer, and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b.	Any fraud, whether material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: May 28, 2024

By:

/s/ Louisa Sanfratello

Louisa Sanfratello

Chief Financial Officer

(Principal Financial and Accounting Officer)

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Fawad Maqbool, the President and Chief Executive Officer of AmpliTech Group, Inc. (the “Registrant”), certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Quarterly Report on Form 10-Q of the Registrant for the quarter ended March 31, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Date: May 28, 2024

By:

/s/ Fawad Maqbool

Fawad Maqbool

President and Chief Executive Officer

(Principal Executive Officer)

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Louisa Sanfratello, Chief Financial Officer of AmpliTech Group, Inc. (the “Registrant”), certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to her knowledge, the Quarterly Report on Form 10-Q of the Registrant for the quarter ended March 31, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Dated: May 28, 2024

By:

/s/ Louisa Sanfratello

Louisa Sanfratello

Chief Financial Officer

(Principal Financial and Accounting Officer)

Cover - shares	3 Months Ended
Cover - shares	Mar. 31, 2024	May 23, 2024
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	001-40069
Entity Registrant Name	AmpliTech Group, Inc.
Entity Central Index Key	0001518461
Entity Tax Identification Number	27-4566352
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	155 Plant Avenue
Entity Address, City or Town	Hauppauge
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11788
City Area Code	(631)
Local Phone Number	521-7831
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		9,717,113
Common Stock, par value $0.001 per share
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	AMPG
Security Exchange Name	NASDAQ
Warrants to Purchase Common Stock
Title of 12(b) Security	Warrants to Purchase Common Stock
Trading Symbol	AMPGW
Security Exchange Name	NASDAQ

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 2,376,894	$ 6,726,013
Accounts receivable	1,309,400	2,542,710
Inventories, net	7,245,607	6,537,578
Prepaid expenses	1,922,561	1,342,335
Total Current Assets	12,854,462	17,148,636
Property and equipment, net	2,509,365	2,599,448
Operating lease right of use assets	3,403,891	3,538,798
Intangible assets, net	2,946,668	2,984,133
Goodwill	4,696,883	4,696,883
Cost method investment	348,250	348,250
Security deposits	109,480	91,481
Total Assets	26,868,999	31,407,629
Current Liabilities
Accounts payable and accrued expenses	965,273	846,179
Customer deposits	25,616	14,239
Current portion of financing lease obligations	17,003	16,799
Current portion of operating lease obligations	495,595	541,324
Current portion of notes payable	63,196	80,841
Total Current Liabilities	1,566,683	1,499,382
Long-term Liabilities
Financing lease obligations, net of current portion	28,209	32,537
Operating lease obligations, net of current portion	3,086,880	3,171,979
Deferred tax liability	24,000	24,000
Total Liabilities	4,705,772	4,727,898
Commitments and Contingencies
Stockholders’ Equity
Common stock, par value $0.001, 500,000,000 shares authorized, 9,717,113 and 9,714,613 shares issued and outstanding, respectively	9,717	9,715
Additional paid-in capital	36,578,394	36,439,739
Accumulated deficit	(14,424,884)	(9,769,723)
Total Stockholders’ Equity	22,163,227	26,679,731
Total Liabilities and Stockholders’ Equity	$ 26,868,999	$ 31,407,629

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023	May 20, 2014	May 19, 2014
Statement of Financial Position [Abstract]
Common stock, shares par value	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000	500,000,000	50,000,000
Common stock, shares issued	9,717,113	9,714,613
Common stock, shares outstanding	9,717,113	9,714,613

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues	$ 2,293,331	$ 4,112,299
Cost of Goods Sold	1,410,701	2,295,768
Gross Profit	882,630	1,816,531
Operating Expenses
Selling, general and administrative	2,033,747	2,086,912
Research and development	276,755	348,730
Total Operating Expenses	2,310,502	2,435,642
Loss From Operations	(1,427,872)	(619,111)
Other Income (Expenses)
Loss on investment in digital assets	(3,248,911)
Unrealized gain on investments		18,546
Realized gain on investments	25,965	4,828
Interest income (expense), net	(4,343)	13,771
Total Other Income (Expenses)	(3,227,289)	37,145
Net Loss Before Income Taxes	(4,655,161)	(581,966)
Provision For Income Taxes
Net Loss	$ (4,655,161)	$ (581,966)
Net Loss Per Share - Basic	$ (0.48)	$ (0.06)
Net Loss Per Share - Diluted	$ (0.48)	$ (0.06)
Weighted Average Common Shares Outstanding - Basic	9,715,712	9,635,709
Weighted Average Common Shares Outstanding - Diluted	9,715,712	9,635,709

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2022	$ 9,635	$ 36,050,161	$ (7,304,284)	$ 28,755,512
Balance, shares at Dec. 31, 2022	9,634,613
Stock based compensation		66,041		66,041
Common stock issued for vesting of RSU’s	$ 2	(2)
Common stock issued for vesting of RSUs, shares	2,500
Net loss			(581,966)	(581,966)
Balance at Mar. 31, 2023	$ 9,637	36,116,200	(7,886,250)	28,239,587
Balance, shares at Mar. 31, 2023	9,637,113
Balance at Dec. 31, 2023	$ 9,715	36,439,739	(9,769,723)	26,679,731
Balance, shares at Dec. 31, 2023	9,714,613
Stock based compensation		138,657		138,657
Common stock issued for vesting of RSU’s	$ 2	(2)
Common stock issued for vesting of RSUs, shares	2,500
Net loss			(4,655,161)	(4,655,161)
Balance at Mar. 31, 2024	$ 9,717	$ 36,578,394	$ (14,424,884)	$ 22,163,227
Balance, shares at Mar. 31, 2024	9,717,113

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows from Operating Activities:
Net loss	$ (4,655,161)	$ (581,966)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	129,123	114,445
Operating lease costs	134,907	150,045
Stock based compensation	138,657	66,041
Inventory reserve	3,000
Loss on investment of digital assets	3,248,911
Change in fair value of marketable securities		(18,546)
Changes in Operating Assets and Liabilities:
Accounts receivable	1,233,310	(55,750)
Inventories	(711,029)	62,256
Prepaid expenses	(580,226)	(422,384)
Security deposits	(17,999)	3,751
Accounts payable and accrued expenses	119,094	226,524
Operating lease obligations	(130,828)	(54,779)
Customer deposits	11,377	(142,143)
Net cash used in operating activities	(1,076,864)	(652,506)
Cash Flows from Investing Activities:
Purchase of property and equipment	(1,575)	(51,669)
Purchase of investment in digital assets	(3,248,911)
Net investment in marketable securities		(2,755,922)
Net cash used in investing activities	(3,250,486)	(2,807,591)
Cash Flows from Financing Activities:
Repayment on financing lease liabilities	(4,124)	(12,611)
Repayment of notes payable	(17,645)	(41,322)
Payment of revenue earnout		(2,180,826)
Net cash used in financing activities	(21,769)	(2,234,759)
Net change in cash and cash equivalents	(4,349,119)	(5,694,856)
Cash and Cash Equivalents, Beginning of the Period	6,726,013	13,290,222
Cash and Cash Equivalents, End of the Period	2,376,894	7,595,366
Supplemental disclosures:
Cash paid for interest expense	6,142	7,930
Cash paid for income taxes
Non-Cash Investing and Financing Activities:
Common Stock issued on vesting of RSUs	$ 2	$ 2

Organization and Business Description

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Organization and Business Description

(1) Organization and Business Description

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Loss on Investment of Digital Assets

3 Months Ended

Mar. 31, 2024

Loss On Investment Of Digital Assets

Loss on Investment of Digital Assets

(2) Loss on Investment of Digital Assets

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

(3) Summary of Significant Accounting Policies

Basis of Accounting

The accompanying condensed consolidated financial statements have been prepared using the accrual basis of accounting.

Principles of Consolidation

Use of Estimates

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Cash and Cash Equivalents

Accounts Receivable

An allowance of $ 0 has been recorded at March 31, 2024 and December 31, 2023, respectively.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Inventories

Inventories, which consist primarily of raw materials, work in progress and finished goods, are stated at the lower of cost (first-in, first-out basis) or market (net realizable value).

As of March 31, 2024 and December 31, 2023 the reserve for inventory obsolescence was $1,149,000 and $1,146,000, respectively.

Property and Equipment

Property and equipment are depreciated as follows:

Description	Useful Life	Method
Office equipment	3 to 7 years	Straight-line
Machinery/shop equipment	7 to 15 years	Straight-line
Computer equipment/software	1 to 7 years	Straight-line
Vehicles	5 years	Straight-line
Leasehold improvements	7 years	Straight-line

Intangible Assets

Intangible assets are amortized as follows:

Schedule of Intangible Assets

Description	Useful Life	Method
Trade names	Indefinite	N/A
Customer relationships	15 to 20 years	Straight-line
Intellectual property	15 years	Straight-line

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Long-Lived Assets

Goodwill and Indefinite-Lived Intangible Assets

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

During the three months ended March 31, 2024 and the year ended December 31, 2023, there were no impairments of indefinite-lived intangible assets.

Investment Policy-Cost Method

Investment in Digital Assets

Leases

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Revenue Recognition

Identify the performance obligations in the contract. Our contracts with customers do not include multiple performance obligations to be completed over a period.

We do not have significant returns. We do not typically offer extended warranty or service plans.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Cost of Sales

We include product costs such material, direct labor, overhead costs, production-related depreciation expense, outside labor and production supplies in cost of sales.

Shipping and Handling

Research and Development

Research and development expenditures are charged to operations as incurred. The major components of research and development costs include payroll, consultants, outside service, and supplies.

Research and development costs for the three months ended March 31, 2024 and 2023 were $276,755 and $348,730, respectively.

Income Taxes

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Earnings Per Share

Fair Value Measurements

Level 1: Unadjusted quoted prices that are available in active markets for identical assets or liabilities at the measurement date.

Level 2: Significant other observable inputs available at the measurement date, other than quoted prices included in Level 1, either directly or indirectly.

Level 3: Significant unobservable inputs that cannot be corroborated by observable market data and reflect the use of significant management judgment.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Stock-Based Compensation

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash and cash equivalents, marketable securities and accounts receivable.

Recent Issued Accounting Pronouncements

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Revenues

3 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

Revenues

(4) Revenues

The following table presents sales disaggregated based on geographic regions and for the three months ended:

Schedule of disaggregated revenue

	March 31, 2024		March 31, 2023
AmpliTech Inc. and Specialty Microwave
Domestic sales	$	678,182	$	1,024,245
International sales		362,685		197,954
Total sales	$	1,040,867	$	1,222,199

Spectrum
Domestic sales	$	781,007	$	1,877,693
International sales		471,457		1,012,407
Total sales	$	1,252,464	$	2,890,100

Total sales		2,293,331	$	4,112,299

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Segment Reporting

3 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Segment Reporting

(5) Segment Reporting

The following table presents summary information by segment for the three months ended March 31, 2024:

Schedule of Segment Reporting

	AmpliTech Inc. And Specialty			Spectrum			Corporate			Total
Revenue	$	1,040,867		$	1,252,464			-		$	2,293,331
Cost of Goods Sold		775,471			635,230			-			1,410,701
Net Loss		(1,004,973	)		(48,947	)		(3,601,241	)		(4,655,161	)
Total Assets		10,980,634			15,386,131			502,234			26,868,999
Depreciation and Amortization		100,201			28,922			-			129,123
Interest Expense, net		1,680			-			2,663			4,343

The following table presents summary information by segment for the three months ended March 31, 2023:

	AmpliTech Inc. And Specialty			Spectrum			Corporate			Total
Revenue	$	1,222,199		$	2,890,100			-		$	4,112,299
Cost of Goods Sold		760,179			1,535,589			-			2,295,768
Net Income (Loss)		(1,009,532	)		720,854			(293,288	)		(581,966	)
Total Assets		13,870,908			16,946,958			3,140,686			33,958,552
Depreciation and Amortization		82,175			32,270			-			114,445
Interest Income (Expense), net		16,939			(75	)		(3,093	)		13,771

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Inventories

3 Months Ended

Mar. 31, 2024

Inventory Disclosure [Abstract]

Inventories

(6) Inventories

The inventory consists of the following at March 31, 2024 and December 31, 2023:

Schedule of Inventory

	March 31, 2024			December 31, 2023

Raw Materials	$	1,252,168		$	959,645
Work-in Progress		79,608			51,140
Finished Goods		7,062,832			6,672,793
Subtotal	$	8,394,607		$	7,683,578
Less: Reserve for Obsolescence		(1,149,000	)		(1,146,000	)

Total	$	7,245,607		$	6,537,578

Property and Equipment

3 Months Ended

Mar. 31, 2024

Property, Plant and Equipment [Abstract]

Property and Equipment

(7) Property and Equipment

Property and Equipment consisted of the following at March 31, 2024 and December 31, 2023:

Schedule of Property and Equipment

	March 31, 2024			December 31, 2023

Lab Equipment	$	3,400,207		$	3,400,207
Manufacturing Equipment		129,745			129,745
Automobiles		7,335			7,335
Computer Equipment and Software		195,813			194,238
Leasehold Improvements		84,172			84,172
Furniture and Fixtures		170,643			170,643

Subtotal		3,987,915			3,986,340
Property plant and equipment, gross		3,987,915			3,986,340
Less: Accumulated Depreciation		(1,478,550	)		(1,386,892	)

Total	$	2,509,365		$	2,599,448
Property plant and equipment, net	$	2,509,365		$	2,599,448

Depreciation expense for the three months ended March 31, 2024 and 2023 was $91,658 and $77,092 respectively, of which $71,124 and $57,894, respectively were included in cost of goods sold.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Goodwill and Intangible Assets

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

(8) Goodwill and Intangible Assets

Goodwill

Other Intangible Assets

Intangible assets with an estimated useful life of fifteen and twenty years consisted of the following at March 31, 2024:

Schedule of Intangible Assets

	Gross Carrying		Accumulated				Weighted
	Amount		Amortization		Net		Average Life
Trade name	$	584,517	$	-	$	584,517		Indefinite
Customer relationships		2,591,491		370,426		2,221,065		16.56
Intellectual Property		202,771		61,685		141,086		10.46

Total	$	3,378,779	$	432,111	$	2,946,668

Amortization expense for the three months ended March 31, 2024 and 2023 was $37,465 and $37,353, respectively.

Annual amortization of intangible assets are as follows:

Schedule of Amortization of Assets


2024		112,508
2025		149,974
2026		149,974
2027		149,974
2028		149,974
Thereafter		1,649,747
Total	$	2,362,151

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Cost Method Investment

3 Months Ended

Mar. 31, 2024

Investments, All Other Investments [Abstract]

Cost Method Investment

(9) Cost Method Investment

Leases

3 Months Ended

Mar. 31, 2024

Leases [Abstract]

Leases

(10) Leases

The following was included in our balance sheet as of March 31, 2024:

	March 31, 2024
Operating leases
Assets
ROU operating lease assets	$	3,403,891

Liabilities
Current portion of operating lease	$	495,595
Operating lease, net of current portion	$	3,086,880
Total operating lease liabilities	$	3,582,475

Financing leases
Assets
Property and equipment, gross	$	234,036
Accumulated depreciation		(161,494	)
Property and equipment, net	$	72,542

Liabilities
Current portion of financing lease	$	17,003
Financing lease, net of current portion	$	28,209
Total financing lease liabilities	$	45,212

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

The weighted average remaining lease term and weighted average discount rate at March 31, 2024 are as follows:

Weighted average remaining lease term (years)	March 31, 2024
Operating leases		9.28
Financing leases		2.74
Weighted average discount rate
Operating leases		4.46	%
Financing leases		4.71	%

Financing Lease

The Company entered into several 60-month lease agreements to finance certain laboratory and office equipment. As such, the Company has accounted for these transactions as a financing lease.

The following table reconciles future minimum financing lease payments to the discounted lease liability as of March 31, 2024:


2024		14,070
2025		18,195
2026		11,982
2027		3,994
Total lease payments		48,241
Less imputed interest		(3,029	)
Total lease obligations		45,212
Less current obligations		(17,003	)
Long-term lease obligations	$	28,209

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Operating Leases

On November 27, 2019, the Company entered a 39-month agreement to lease an automobile with a monthly payment of $420. This lease was paid in full as of March 31, 2023.

On August 9, 2023, the Company entered a 39-month agreement for $20,880 to lease an automobile with a monthly payment of $605.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

The following table reconciles future minimum operating lease payments to the discounted lease liability as of March 31, 2024:


2024		524,712
2025		407,580
2026		389,397
2027		393,899
2028		404,721
Thereafter		2,313,460
Total lease payments		4,433,770
Less imputed interest		(851,295	)
Total lease obligations		3,582,475
Less current obligations		(495,595	)
Long-term lease obligations	$	3,086,880

Notes Payable

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Notes Payable

(11) Notes Payable

Promissory Note:

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Loan Payable:

	●	On May 14, 2020, the Company borrowed $27,494 to be paid over a three-year term with monthly payments of $815 at an interest rate of 4.27%. The balance as of March 31, 2024 and 2023 was $0 and $812, respectively. Principal payments of $0 and $2,418, were paid for the three months ended March 31, 2024 and 2023, respectively. Total interest expense paid for the three months ended March 31, 2024 and 2023 was $0 and $27, respectively. This loan was paid in full in April 2023.

	●	On June 10, 2020, the Company borrowed $41,015 to be paid over a three-year term with monthly payments of $1,216 at an interest rate of 4.28%. The balance as of March 31, 2024 and 2023 was $0 and $2,418, respectively. Principal payments of $0 and $3,593 were made for the three months ended March 31, 2024 and 2023, respectively. Total interest expense paid for the three months ended March 31, 2024 and 2023 was $0 and $55, respectively. This loan was paid in full in May 2023.

Future principal payments over the term of the loans as of March 31, 2024 are as follows:

	Payments
2024	$	63,196
Total remaining payments	$	63,196

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Stockholders’ Equity

3 Months Ended

Mar. 31, 2024

Equity [Abstract]

Stockholders’ Equity

(12) Stockholders’ Equity

Preferred Stock

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Common Stock:

On February 17, 2021, AmpliTech Group Inc., common stock and warrants under the symbols “AMPG” and “AMPGW”, respectively, commenced trading on NASDAQ.

2020 Equity Incentive Plan:

Stock Options:

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Below is a table summarizing the changes in stock options outstanding for the three months ended March 31, 2024:

Schedule of Stock Options Outstanding

	Number of		Weighted Average
	Options		Exercise Price ($)
Outstanding at December 31, 2023		1,236,000	$	2.30
Granted		57,500	$	2.15
Exercised		-		-
Expired		-		-
Outstanding at March 31, 2024		1,293,500	$	2.30
Exercisable at March 31, 2024		553,953	$	2.83

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Warrants:

Below is a table summarizing the changes in warrants outstanding for the three months ended March 31, 2024:

Schedule of Warrants Outstanding

	Number of		Weighted Average
	Warrants		Exercise Price ($)
Outstanding at December 31, 2023		3,296,942	$	7.83
Granted		-		-
Exercised		-		-
Expired		-		-
Outstanding at March 31, 2024		3,296,942	$	7.83
Exercisable at March 31, 2024		3,296,942	$	7.83

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Restricted Stock Units:

Below is a table summarizing the changes in restricted stock units outstanding for the three months ended March 31, 2024:

	Number of			Weighted Average
	RSU’s			Exercise Price ($)
Outstanding at December 31, 2023		12,500			1.96
Granted		-			-
Exercised		(2,500	)	$	1.96
Expired		-			-
Outstanding at March 31, 2024		10,000		$	1.96
Exercisable at March 31, 2024		-			-

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Basis of Accounting

Basis of Accounting

The accompanying condensed consolidated financial statements have been prepared using the accrual basis of accounting.

Principles of Consolidation

Principles of Consolidation

Use of Estimates

Use of Estimates

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Cash and Cash Equivalents

Cash and Cash Equivalents

Accounts Receivable

Accounts Receivable

An allowance of $ 0 has been recorded at March 31, 2024 and December 31, 2023, respectively.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Inventories

Inventories

Inventories, which consist primarily of raw materials, work in progress and finished goods, are stated at the lower of cost (first-in, first-out basis) or market (net realizable value).

As of March 31, 2024 and December 31, 2023 the reserve for inventory obsolescence was $1,149,000 and $1,146,000, respectively.

Property and Equipment

Property and Equipment

Property and equipment are depreciated as follows:

Description	Useful Life	Method
Office equipment	3 to 7 years	Straight-line
Machinery/shop equipment	7 to 15 years	Straight-line
Computer equipment/software	1 to 7 years	Straight-line
Vehicles	5 years	Straight-line
Leasehold improvements	7 years	Straight-line

Intangible Assets

Intangible Assets

Intangible assets are amortized as follows:

Schedule of Intangible Assets

Description	Useful Life	Method
Trade names	Indefinite	N/A
Customer relationships	15 to 20 years	Straight-line
Intellectual property	15 years	Straight-line

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Long-Lived Assets

Long-Lived Assets

Goodwill and Indefinite-Lived Intangible Assets

Goodwill and Indefinite-Lived Intangible Assets

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

During the three months ended March 31, 2024 and the year ended December 31, 2023, there were no impairments of indefinite-lived intangible assets.

Investment Policy-Cost Method

Investment Policy-Cost Method

Investment in Digital Assets

Investment in Digital Assets

Leases

Leases

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Revenue Recognition

Revenue Recognition

Identify the performance obligations in the contract. Our contracts with customers do not include multiple performance obligations to be completed over a period.

We do not have significant returns. We do not typically offer extended warranty or service plans.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Cost of Sales

Cost of Sales

We include product costs such material, direct labor, overhead costs, production-related depreciation expense, outside labor and production supplies in cost of sales.

Shipping and Handling

Shipping and Handling

Research and Development

Research and Development

Research and development expenditures are charged to operations as incurred. The major components of research and development costs include payroll, consultants, outside service, and supplies.

Research and development costs for the three months ended March 31, 2024 and 2023 were $276,755 and $348,730, respectively.

Income Taxes

Income Taxes

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Earnings Per Share

Earnings Per Share

Fair Value Measurements

Fair Value Measurements

Level 1: Unadjusted quoted prices that are available in active markets for identical assets or liabilities at the measurement date.

Level 2: Significant other observable inputs available at the measurement date, other than quoted prices included in Level 1, either directly or indirectly.

Level 3: Significant unobservable inputs that cannot be corroborated by observable market data and reflect the use of significant management judgment.

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Stock-Based Compensation

Stock-Based Compensation

Concentration of Credit Risk

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash and cash equivalents, marketable securities and accounts receivable.

Recent Issued Accounting Pronouncements

Recent Issued Accounting Pronouncements

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Schedule of property and equipment depreciated

Property and equipment are depreciated as follows:

Description	Useful Life	Method
Office equipment	3 to 7 years	Straight-line
Machinery/shop equipment	7 to 15 years	Straight-line
Computer equipment/software	1 to 7 years	Straight-line
Vehicles	5 years	Straight-line
Leasehold improvements	7 years	Straight-line

Schedule of Intangible Assets

Description	Useful Life	Method
Trade names	Indefinite	N/A
Customer relationships	15 to 20 years	Straight-line
Intellectual property	15 years	Straight-line

Revenues (Tables)

3 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of disaggregated revenue

The following table presents sales disaggregated based on geographic regions and for the three months ended:

Schedule of disaggregated revenue

	March 31, 2024		March 31, 2023
AmpliTech Inc. and Specialty Microwave
Domestic sales	$	678,182	$	1,024,245
International sales		362,685		197,954
Total sales	$	1,040,867	$	1,222,199

Spectrum
Domestic sales	$	781,007	$	1,877,693
International sales		471,457		1,012,407
Total sales	$	1,252,464	$	2,890,100

Total sales		2,293,331	$	4,112,299

Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Schedule of Segment Reporting

The following table presents summary information by segment for the three months ended March 31, 2024:

Schedule of Segment Reporting

	AmpliTech Inc. And Specialty			Spectrum			Corporate			Total
Revenue	$	1,040,867		$	1,252,464			-		$	2,293,331
Cost of Goods Sold		775,471			635,230			-			1,410,701
Net Loss		(1,004,973	)		(48,947	)		(3,601,241	)		(4,655,161	)
Total Assets		10,980,634			15,386,131			502,234			26,868,999
Depreciation and Amortization		100,201			28,922			-			129,123
Interest Expense, net		1,680			-			2,663			4,343

The following table presents summary information by segment for the three months ended March 31, 2023:

	AmpliTech Inc. And Specialty			Spectrum			Corporate			Total
Revenue	$	1,222,199		$	2,890,100			-		$	4,112,299
Cost of Goods Sold		760,179			1,535,589			-			2,295,768
Net Income (Loss)		(1,009,532	)		720,854			(293,288	)		(581,966	)
Total Assets		13,870,908			16,946,958			3,140,686			33,958,552
Depreciation and Amortization		82,175			32,270			-			114,445
Interest Income (Expense), net		16,939			(75	)		(3,093	)		13,771

Inventories (Tables)

3 Months Ended

Mar. 31, 2024

Inventory Disclosure [Abstract]

Schedule of Inventory

The inventory consists of the following at March 31, 2024 and December 31, 2023:

Schedule of Inventory

	March 31, 2024			December 31, 2023

Raw Materials	$	1,252,168		$	959,645
Work-in Progress		79,608			51,140
Finished Goods		7,062,832			6,672,793
Subtotal	$	8,394,607		$	7,683,578
Less: Reserve for Obsolescence		(1,149,000	)		(1,146,000	)

Total	$	7,245,607		$	6,537,578

Property and Equipment (Tables)

3 Months Ended

Mar. 31, 2024

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment

Property and Equipment consisted of the following at March 31, 2024 and December 31, 2023:

Schedule of Property and Equipment

	March 31, 2024			December 31, 2023

Lab Equipment	$	3,400,207		$	3,400,207
Manufacturing Equipment		129,745			129,745
Automobiles		7,335			7,335
Computer Equipment and Software		195,813			194,238
Leasehold Improvements		84,172			84,172
Furniture and Fixtures		170,643			170,643

Subtotal		3,987,915			3,986,340
Property plant and equipment, gross		3,987,915			3,986,340
Less: Accumulated Depreciation		(1,478,550	)		(1,386,892	)

Total	$	2,509,365		$	2,599,448
Property plant and equipment, net	$	2,509,365		$	2,599,448

Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

Intangible assets with an estimated useful life of fifteen and twenty years consisted of the following at March 31, 2024:

Schedule of Intangible Assets

	Gross Carrying		Accumulated				Weighted
	Amount		Amortization		Net		Average Life
Trade name	$	584,517	$	-	$	584,517		Indefinite
Customer relationships		2,591,491		370,426		2,221,065		16.56
Intellectual Property		202,771		61,685		141,086		10.46

Total	$	3,378,779	$	432,111	$	2,946,668

Schedule of Amortization of Assets

Annual amortization of intangible assets are as follows:

Schedule of Amortization of Assets


2024		112,508
2025		149,974
2026		149,974
2027		149,974
2028		149,974
Thereafter		1,649,747
Total	$	2,362,151

Leases (Tables)

3 Months Ended

Mar. 31, 2024

Leases [Abstract]

Schedule of Lease Assets and Liabilities

The following was included in our balance sheet as of March 31, 2024:

	March 31, 2024
Operating leases
Assets
ROU operating lease assets	$	3,403,891

Liabilities
Current portion of operating lease	$	495,595
Operating lease, net of current portion	$	3,086,880
Total operating lease liabilities	$	3,582,475

Financing leases
Assets
Property and equipment, gross	$	234,036
Accumulated depreciation		(161,494	)
Property and equipment, net	$	72,542

Liabilities
Current portion of financing lease	$	17,003
Financing lease, net of current portion	$	28,209
Total financing lease liabilities	$	45,212

Schedule of Weighted Average Remaining Lease Term and Weighted Average Discount Rate

The weighted average remaining lease term and weighted average discount rate at March 31, 2024 are as follows:

Weighted average remaining lease term (years)	March 31, 2024
Operating leases		9.28
Financing leases		2.74
Weighted average discount rate
Operating leases		4.46	%
Financing leases		4.71	%

Schedule Of Future Minimum Lease Payments For Finance Lease

The following table reconciles future minimum financing lease payments to the discounted lease liability as of March 31, 2024:


2024		14,070
2025		18,195
2026		11,982
2027		3,994
Total lease payments		48,241
Less imputed interest		(3,029	)
Total lease obligations		45,212
Less current obligations		(17,003	)
Long-term lease obligations	$	28,209

Schedule of Future Minimum Operating Lease Payments

The following table reconciles future minimum operating lease payments to the discounted lease liability as of March 31, 2024:


2024		524,712
2025		407,580
2026		389,397
2027		393,899
2028		404,721
Thereafter		2,313,460
Total lease payments		4,433,770
Less imputed interest		(851,295	)
Total lease obligations		3,582,475
Less current obligations		(495,595	)
Long-term lease obligations	$	3,086,880

Notes Payable (Tables)

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Schedule of Future Principal and Interest Payments

Future principal payments over the term of the loans as of March 31, 2024 are as follows:

	Payments
2024	$	63,196
Total remaining payments	$	63,196

Stockholders’ Equity (Tables)

3 Months Ended

Mar. 31, 2024

Equity [Abstract]

Schedule of Stock Options Outstanding

Below is a table summarizing the changes in stock options outstanding for the three months ended March 31, 2024:

Schedule of Stock Options Outstanding

	Number of		Weighted Average
	Options		Exercise Price ($)
Outstanding at December 31, 2023		1,236,000	$	2.30
Granted		57,500	$	2.15
Exercised		-		-
Expired		-		-
Outstanding at March 31, 2024		1,293,500	$	2.30
Exercisable at March 31, 2024		553,953	$	2.83

Schedule of Warrants Outstanding

Below is a table summarizing the changes in warrants outstanding for the three months ended March 31, 2024:

Schedule of Warrants Outstanding

	Number of		Weighted Average
	Warrants		Exercise Price ($)
Outstanding at December 31, 2023		3,296,942	$	7.83
Granted		-		-
Exercised		-		-
Expired		-		-
Outstanding at March 31, 2024		3,296,942	$	7.83
Exercisable at March 31, 2024		3,296,942	$	7.83

Schedule of Changes in Restricted Stock Units Outstanding

Below is a table summarizing the changes in restricted stock units outstanding for the three months ended March 31, 2024:

	Number of			Weighted Average
	RSU’s			Exercise Price ($)
Outstanding at December 31, 2023		12,500			1.96
Granted		-			-
Exercised		(2,500	)	$	1.96
Expired		-			-
Outstanding at March 31, 2024		10,000		$	1.96
Exercisable at March 31, 2024		-			-

Organization and Business Description (Details Narrative) - $ / shares	Feb. 17, 2021	Aug. 13, 2012	Mar. 31, 2024	Dec. 31, 2023	Aug. 12, 2012
Restructuring Cost and Reserve [Line Items]
Common stock, outstanding			9,717,113	9,714,613
Reverse stock split	1-for-20
IPO [Member]
Restructuring Cost and Reserve [Line Items]
Public offering shares	1,371,428
Public offering per share	$ 7.00
Amplitech Inc [Member]
Restructuring Cost and Reserve [Line Items]
Common stock, outstanding					893,750
Amplitech Inc [Member]
Restructuring Cost and Reserve [Line Items]
Acquisition of entity by issuing of common stock		833,750
Percentage of voting interest acquired		100.00%
Equity interests owned by selling share holders		60,000

Loss on Investment of Digital Assets (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Loss On Investment Of Digital Assets
Transactions in digital currency	$ 3,250,000
Loss from the investment in digital assets	3,248,911
Remaining balance on investment of digital assets	$ 0

Schedule of property and equipment depreciated (Details)	3 Months Ended
	Mar. 31, 2024
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Depreciation Method	Straight-line
Office Equipment [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	3 years
Office Equipment [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	7 years
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Depreciation Method	Straight-line
Machinery and Equipment [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	7 years
Machinery and Equipment [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	15 years
Computer Equipment Software [Member]
Property, Plant and Equipment [Line Items]
Depreciation Method	Straight-line
Computer Equipment Software [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	1 year
Computer Equipment Software [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	7 years
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	5 years
Depreciation Method	Straight-line
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	7 years
Depreciation Method	Straight-line

Schedule of Intangible Assets (Details) - USD ($)	3 Months Ended
Schedule of Intangible Assets (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Accumulated Amortization	$ 432,111
Net	2,362,151
Gross Carrying Amount	3,378,779
Net	$ 2,946,668	$ 2,984,133
Customer Relationships [Member]
Property, Plant and Equipment [Line Items]
Depreciation Method	Straight-line
Gross Carrying Amount	$ 2,591,491
Accumulated Amortization	370,426
Net	$ 2,221,065
Weighted Average Life	16 years 6 months 21 days
Customer Relationships [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Useful Life	15 years
Customer Relationships [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Useful Life	20 years
Intellectual Property [Member]
Property, Plant and Equipment [Line Items]
Useful Life	15 years
Depreciation Method	Straight-line
Gross Carrying Amount	$ 202,771
Accumulated Amortization	61,685
Net	$ 141,086
Weighted Average Life	10 years 5 months 15 days
Trade Names [Member]
Property, Plant and Equipment [Line Items]
Gross Carrying Amount	$ 584,517
Accumulated Amortization
Net	$ 584,517

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
FDIC Maximum amount	$ 1,594,791		$ 3,170,500
Allowance for doubtful accounts receivable	0		0
Inventory obsolescence reserve	1,149,000		1,146,000
Goodwill impairment	0		0
Cost method investment	348,250		$ 348,250
Research and development	$ 276,755	$ 348,730
Potentially dilutive shares	4,600,442	4,234,942
Maximum [Member]
Property, Plant and Equipment [Line Items]
FDIC Maximum amount	$ 250,000

Schedule of disaggregated revenue (Details) - USD ($)	3 Months Ended
Schedule of disaggregated revenue (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Total sales	$ 2,293,331	$ 4,112,299
Amplitech Incand Specialty Microwave [Member] \| Domestic Sales [Member]
Disaggregation of Revenue [Line Items]
Total sales	678,182	1,024,245
Amplitech Incand Specialty Microwave [Member] \| International Sales [Member]
Disaggregation of Revenue [Line Items]
Total sales	362,685	197,954
Amplitech Inc [Member]
Disaggregation of Revenue [Line Items]
Total sales	1,040,867	1,222,199
Spectrum [Member]
Disaggregation of Revenue [Line Items]
Total sales	1,252,464	2,890,100
Spectrum [Member] \| Domestic Sales [Member]
Disaggregation of Revenue [Line Items]
Total sales	781,007	1,877,693
Spectrum [Member] \| International Sales [Member]
Disaggregation of Revenue [Line Items]
Total sales	$ 471,457	$ 1,012,407

Schedule of Segment Reporting (Details) - USD ($)	3 Months Ended
Schedule of Segment Reporting (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Segment Reporting Information [Line Items]
Revenue	$ 2,293,331	$ 4,112,299
Cost of Goods Sold	1,410,701	2,295,768
Net Income (Loss)	(4,655,161)	(581,966)
Total Assets	26,868,999	33,958,552	$ 31,407,629
Depreciation and Amortization	129,123	114,445
Interest Income, net	(4,343)	13,771
Amplitech Inc And Specialty [Member]
Segment Reporting Information [Line Items]
Revenue	1,040,867	1,222,199
Cost of Goods Sold	775,471	760,179
Net Income (Loss)	(1,004,973)	(1,009,532)
Total Assets	10,980,634	13,870,908
Depreciation and Amortization	100,201	82,175
Interest Income, net	1,680	16,939
Spectrum [Member]
Segment Reporting Information [Line Items]
Revenue	1,252,464	2,890,100
Cost of Goods Sold	635,230	1,535,589
Net Income (Loss)	(48,947)	720,854
Total Assets	15,386,131	16,946,958
Depreciation and Amortization	28,922	32,270
Interest Income, net		(75)
Corporates [Member]
Segment Reporting Information [Line Items]
Revenue
Cost of Goods Sold
Net Income (Loss)	(3,601,241)	(293,288)
Total Assets	502,234	3,140,686
Depreciation and Amortization
Interest Income, net	$ 2,663	$ (3,093)

Schedule of Inventory (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw Materials	$ 1,252,168	$ 959,645
Work-in Progress	79,608	51,140
Finished Goods	7,062,832	6,672,793
Subtotal	8,394,607	7,683,578
Less: Reserve for Obsolescence	(1,149,000)	(1,146,000)
Total	$ 7,245,607	$ 6,537,578

Schedule of Property and Equipment (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property plant and equipment, gross	$ 3,987,915	$ 3,986,340
Less: Accumulated Depreciation	(1,478,550)	(1,386,892)
Property plant and equipment, net	2,509,365	2,599,448
Lab Equipment [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment, gross	3,400,207	3,400,207
Manufacturing Equipment [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment, gross	129,745	129,745
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment, gross	7,335	7,335
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment, gross	195,813	194,238
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment, gross	84,172	84,172
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment, gross	$ 170,643	$ 170,643

Property and Equipment (Details Narrative) - USD ($)	3 Months Ended
Property and Equipment (Details Narrative) - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 91,658	$ 77,092
Cost of goods sold	71,124	57,894
Amount paid to purchase Property and equipment under finance lease	234,036
Financing leases outstanding balance	$ 45,212	$ 70,205

Schedule of Amortization of Assets (Details)	Mar. 31, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2024	$ 112,508
2025	149,974
2026	149,974
2027	149,974
2028	149,974
Thereafter	1,649,747
Net	$ 2,362,151

Goodwill and Intangible Assets (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 4,696,883		$ 4,696,883
Amortization expenses	$ 37,465	$ 37,353

Cost Method Investment (Details Narrative) - SN2NLLC [Member] - USD ($)	Jun. 10, 2021	Mar. 31, 2024	Jun. 15, 2022
Defined Benefit Plan Disclosure [Line Items]
Aggregate purchase price for membership interest	$ 350,000
Equity method investment additional information	Each tranche represented a 5% membership interest, and in aggregate a 20% membership interest.
Cost method investment membership interest percentage			19.90%
Overpaid for the membership interest			$ 1,750
Investments		$ 348,250
Cost method investment membership interest percentage		19.90%

Schedule of Lease Assets and Liabilities (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023
Leases [Abstract]
ROU operating lease assets	$ 3,403,891	$ 3,538,798
Current portion of operating lease	495,595	541,324
Operating lease, net of current portion	3,086,880	3,171,979
Total operating lease liabilities	3,582,475
Property and equipment, gross	234,036
Accumulated depreciation	(161,494)
Property and equipment, net	72,542
Current portion of financing lease	17,003	16,799
Financing lease, net of current portion	28,209	$ 32,537
Total financing lease liabilities	$ 45,212		$ 70,205

Schedule of Weighted Average Remaining Lease Term and Weighted Average Discount Rate (Details)	Mar. 31, 2024
Leases [Abstract]
Operating leases	9 years 3 months 10 days
Financing leases	2 years 8 months 26 days
Operating leases	4.46%
Financing leases	4.71%

Schedule Of Future Minimum Lease Payments For Finance Lease (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Leases [Abstract]
2024	$ 14,070
2025	18,195
2026	11,982
2027	3,994
Total lease payments	48,241
Less imputed interest	(3,029)
Total lease obligations	45,212	$ 70,205
Less current obligations	(17,003)
Long-term lease obligations	$ 28,209

Schedule of Future Minimum Operating Lease Payments (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Leases [Abstract]
2024	$ 524,712
2025	407,580
2026	389,397
2027	393,899
2028	404,721
Thereafter	2,313,460
Total lease payments	4,433,770
Less imputed interest	(851,295)
Total operating lease liabilities	3,582,475
Less current obligations	(495,595)	$ (541,324)
Long-term lease obligations	$ 3,086,880	$ 3,171,979

Leases (Details Narrative)								3 Months Ended
Leases (Details Narrative)	Jan. 15, 2024 USD ($) ft²	Aug. 09, 2023 USD ($)	Dec. 15, 2021 USD ($)	Oct. 15, 2021 USD ($) ft²	Nov. 27, 2019 USD ($)	Sep. 12, 2019 USD ($)	Sep. 12, 2019	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Finance lease agreement description								The Company entered into several 60-month lease agreements to finance certain laboratory and office equipment.
Operating lease agreement description						the Company entered into a new operating lease agreement to rent office space in Ronkonkoma, NY. This five- year agreement commenced
Annual rent		$ 20,880				$ 90,000
Operating lease payments increase percentage	2.50%			2.75%		3.00%
Purchase option description							The Company has an option to buy the property during the first two years of the lease for $1,200,000 and then at fair market value for the remainder of the lease term.
Gain loss on termination of lease right of use operating								$ 8,461
Payments for rent	$ 53,675	$ 605		$ 346,242	$ 420
New lease for facility \| ft²				20,000
Lessee operating lease term of contract	5 years 1 month			7 years 2 months
Security deposit	$ 17,999			$ 86,560				$ 109,480	$ 91,481
Lessee operating lease description		On August 9, 2023, the Company entered a 39-month agreement for $20,880 to lease an automobile with a monthly payment of $605.
Triple lease for facility \| ft²	1,900
Lease Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Operating lease payments increase percentage			3.00%
Base rent			$ 24,234

Schedule of Future Principal and Interest Payments (Details)	Mar. 31, 2024 USD ($)
Debt Disclosure [Abstract]
2024	$ 63,196
Total remaining payments	$ 63,196

Notes Payable (Details Narrative) - USD ($)					1 Months Ended	3 Months Ended
Notes Payable (Details Narrative) - USD ($)	Jun. 10, 2020	May 14, 2020	Sep. 12, 2019	Sep. 12, 2019	Jan. 31, 2022	Mar. 31, 2024	Mar. 31, 2023	Mar. 14, 2023
Short-Term Debt [Line Items]
Line of credit facility, periodic payment			$ 250,000
Line of credit facility, maximum borrowing capacity			$ 500,000	$ 500,000
Line of credit, clousure of equipment								$ 500,000
Line of credit equipments								$ 0
May 14, 2020 [Member] \| Loans Payable [Member]
Short-Term Debt [Line Items]
Interest rate percentage		4.27%
Principal payment						$ 0	$ 2,418
Interest expense						0	27
Proceeds from loans		$ 27,494
Debt instrument periodic payments interest		$ 815
Repayments of debt						0	812
June 10, 2020 [Member]
Short-Term Debt [Line Items]
Principal payment						0	3,593
Interest expense						0	55
Repayments of debt						0	2,418
June 10, 2020 [Member] \| Loans Payable [Member]
Short-Term Debt [Line Items]
Interest rate percentage	4.28%
Proceeds from loans	$ 41,015
Debt instrument periodic payments interest	$ 1,216
January 2022 [Member]
Short-Term Debt [Line Items]
Interest rate percentage					1.90%
Principal payment						0	10,351
Interest expense						0	182
Repayments of debt						0	$ 31,349
Payments of stock issuance costs					$ 91,795
Payments for deposits					9,180
Machinery financed, balance					$ 82,616
Number of payments					24 payments
Promissory Note [Member]
Short-Term Debt [Line Items]
Considration paid in promissory note				$ 475,000
Interest rate percentage			6.00%	6.00%
Notes payable						63,196
Promissory Note [Member]
Short-Term Debt [Line Items]
Total consideration paid				$ 1,143,633
Cash paid in acquisition, net of cash acquired				$ 668,633
Debt instrument, description				Beginning November 1, 2019, payment of principal and interest shall be due payable in fifty-nine (59) monthly payments of $9,213 with a final payment due October 1, 2024 of $9,203.
Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Principal payment						17,645
Interest expense						$ 782

Schedule of Stock Options Outstanding (Details) - Share-Based Payment Arrangement, Option [Member]	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Outstanding \| shares	1,236,000
Weighted Average Exercise Price, Outstanding \| $ / shares	$ 2.30
Number of Options, Granted \| shares	57,500
Weighted Average Exercise Price, Granted \| $ / shares	$ 2.15
Number of Options, Exercised \| shares
Weighted Average Exercise Price, Exercised \| $ / shares
Number of Options, Expired \| shares
Weighted Average Exercise Price, Expired \| $ / shares
Number of Options, Outstanding \| shares	1,293,500
Weighted Average Exercise Price, Outstanding \| $ / shares	$ 2.30
Number of Options, Exercisable \| shares	553,953
Weighted Average Exercise Price, Exercisable \| $ / shares	$ 2.83

Schedule of Warrants Outstanding (Details) - Warrant [Member]	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Warrants, Outstanding \| shares	3,296,942
Weighted Average Exercise Price, Outstanding \| $ / shares	$ 7.83
Number of Warrants, Granted \| shares
Weighted Average Exercise Price Outstanding, Granted \| $ / shares
Number of Warrants, Exercised \| shares
Weighted Average Exercise Price Outstanding, Exercised \| $ / shares
Number of Warrants,Expired \| shares
Weighted Average Exercise Price Outstanding, Expired \| $ / shares
Number of Warrants, Outstanding \| shares	3,296,942
Weighted Average Exercise Price, Outstanding \| $ / shares	$ 7.83
Number of Warrants, Exercisable \| shares	3,296,942
Weighted Average Exercise Price, Exercisable \| $ / shares	$ 7.83

Schedule of Changes in Restricted Stock Units Outstanding (Details) - Restricted Stock Units (RSUs) [Member]	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of RSU's, Outstanding \| shares	12,500
Weighted Average Exercise Price, Outstanding \| $ / shares	$ 1.96
Number of RSU's, Granted \| shares
Weighted Average Exercise Price, Granted \| $ / shares
Number of RSU's, Exercised \| shares	(2,500)
Weighted Average Exercise Price, Exercised \| $ / shares	$ 1.96
Number of RSU's, Expired \| shares
Weighted Average Exercise Price, Expired \| $ / shares
Number of RSU's, Outstanding \| shares	10,000
Weighted Average Exercise Price, Outstanding \| $ / shares	$ 1.96
Number of RSU's, Exercisable \| shares
Weighted Average Exercise Price, Exercisable \| $ / shares

Stockholders’ Equity (Details Narrative) - USD ($)							3 Months Ended
Stockholders’ Equity (Details Narrative) - USD ($)	Jan. 16, 2024	Jan. 09, 2024	May 20, 2022	Jul. 20, 2021	Jul. 20, 2021	Feb. 19, 2021	Mar. 31, 2024	Dec. 31, 2023	Apr. 16, 2021	Oct. 07, 2020	May 20, 2014	May 19, 2014	Jul. 10, 2013
Accumulated Other Comprehensive Income (Loss) [Line Items]
Corporation authorised shares							501,000,000
Common stock, par value							$ 0.001	$ 0.001
Common stock shares, authorized							500,000,000	500,000,000			500,000,000	50,000,000
Preferred stock, shares authorized							1,000,000			1,000,000			500,000
Preferred stock, shares par value										$ 0.001			$ 0.001
Common stock shares, authorized							50,000,000
Common stock shares issued							9,717,113	9,714,613
Board Advisor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of options, granted				30,000
Ampli Tech Group Inc [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share price				$ 5.00	$ 5.00
Public offering						1,371,428
Share-Based Payment Arrangement, Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Purchase shares of common stock	5,000
Exercise price per share	$ 1.93
Estimated fair value market	$ 8,800
Expected term	7 years 6 months 3 days
Share price	$ 1.93
Exercise price	$ 1.93
Volatility	120.10%
Risk-free rate	4.01%
Stock-based compensation expense							$ 133,786
Unrecognized compensation cost							$ 1,232,708
Weighted average remaining contractual life							4 years 9 months 18 days
Weighted average remaining contractual life							5 years 2 months 19 days
Intrinsic value							$ 61,450
Number of options, granted							57,500
Stock Options [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock shares issuable upon exercise of warrants							811,500
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected term					3 years
Share price				3.80	$ 3.80
Exercise price				$ 5.00	$ 5.00
Volatility					149.80%
Risk-free rate					0.37%
Stock-based compensation expense							$ 0
Common stock shares issued									2,715,000
Warrants to purchase an aggregate shares of common stock									1,900,500
Warrants to purchase an aggregate shares of common stock exercise price									$ 8.48
Unrecognized compensation cost							$ 0
Weighted average remaining contractual life							2 years 2 months 23 days
Intrinsic value							$ 0
Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Estimated fair market value				$ 88,803	$ 88,803
Restricted Stock Units (RSUs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock shares							12,500
Stock-based compensation expense							$ 4,871
Weighted average remaining contractual life							10 months 20 days
Unrecognized compensation cost							$ 22,374
Number of options, granted			30,000
Exercise Price			$ 1.96
Equal quarterly installments, shares			2,500
Total intrinsic value							$ 0
Consultant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Purchase shares of common stock		2,500
Exercise price per share		$ 1.86
Estimated fair value market		$ 3,800
Expected term		5 years
Share price		$ 1.86
Exercise price		$ 1.86
Volatility		116.10%
Risk-free rate		3.97%
Contractor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Purchase shares of common stock	50,000
Exercise price per share	$ 2.19
Estimated fair value market	$ 98,600
Expected term	10 years
Share price	$ 2.19
Exercise price	$ 2.19
Volatility	123.00%
Risk-free rate	4.07%
Contractor [Member] \| Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock option vested	20,000
Contractor [Member] \| Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock option vested	30,000
2020 Equity Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Equity incentive plan, description							In October 2020, the Board of Directors and shareholders adopted the Company’s 2020 Equity Incentive Plan (the “2020 Plan”), effective as of December 14, 2020. Under the 2020 Plan, the Company reserved 1,250,000 shares of common stock to grant shares of the Company’s common stock to employees and individuals who perform services for the Company
2020 Equity Incentive Plan [Member] \| Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock shares							2,250,000
Series A Convertible Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock designated as convertible preferred stock, shares										401,000
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share price						$ 7.00